Year |
Citation |
Score |
2022 |
Demjaha A, Galderisi S, Glenthøj B, Arango C, Mucci A, Lawrence A, O'Daly O, Kempton M, Ciufolini S, Baandrup L, Ebdrup BH, Rodriguez-Jimenez R, Diaz-Marsa M, Díaz-Caneja CM, Winter van Rossum I, ... Kahn R, et al. Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study. Psychological Medicine. 1-9. PMID 35197142 DOI: 10.1017/S0033291722000010 |
0.306 |
|
2021 |
Lehet M, Tso IF, Park S, Neggers SFW, Thompson IA, Kahn RS, Thakkar KN. Altered Effective Connectivity within an Oculomotor Control Network in Unaffected Relatives of Individuals with Schizophrenia. Brain Sciences. 11. PMID 34573248 DOI: 10.3390/brainsci11091228 |
0.316 |
|
2020 |
de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Alonso-Lana S, Bearden CE, Bertolino A, Bonvino A, Bramon E, Buimer EEL, Cahn W, Canales-Rodríguez EJ, Cannon DM, Cannon TD, Caseras X, ... ... Kahn RS, et al. Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder. Human Brain Mapping. PMID 33027543 DOI: 10.1002/hbm.25206 |
0.494 |
|
2020 |
Ormel PR, Böttcher C, Gigase FAJ, Missall RD, van Zuiden W, Fernández Zapata MC, Ilhan D, de Goeij M, Udine E, Sommer IEC, Priller J, Raj T, Kahn RS, Hol EM, de Witte LD. A characterization of the molecular phenotype and inflammatory response of schizophrenia patient-derived microglia-like cells. Brain, Behavior, and Immunity. PMID 32798663 DOI: 10.1016/J.Bbi.2020.08.012 |
0.374 |
|
2020 |
Correll CU, Newcomer JW, Silverman B, DiPetrillo L, Graham C, Jiang Y, Du Y, Simmons A, Hopkinson C, McDonnell D, Kahn RS. Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study. The American Journal of Psychiatry. appiajp202019121279. PMID 32791894 DOI: 10.1176/Appi.Ajp.2020.19121279 |
0.353 |
|
2020 |
Thygesen JH, Presman A, Harju-Seppänen J, Irizar H, Jones R, Kuchenbaecker K, Lin K, Alizadeh BZ, Austin-Zimmerman I, Bartels-Velthuis A, Bhat A, Bruggeman R, Cahn W, Calafato S, Crespo-Facorro B, ... ... Kahn R, et al. Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study. Molecular Psychiatry. PMID 32719466 DOI: 10.1038/S41380-020-0820-7 |
0.391 |
|
2020 |
Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. Cns Spectrums. 1-75. PMID 32594935 DOI: 10.1017/S1092852920001546 |
0.332 |
|
2020 |
Troudet R, Ali WBH, Bacq-Daian D, Rossum IWV, Boland-Auge A, Battail C, Barau C, Rujescu D, McGuire P, Kahn RS, Deleuze JF, Leboyer M, Jamain S. Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32450569 DOI: 10.1038/S41386-020-0703-2 |
0.305 |
|
2020 |
Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, ... Kahn RS, et al. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial. Psychiatry Research. 289: 112970. PMID 32438207 DOI: 10.1016/J.Psychres.2020.112970 |
0.316 |
|
2020 |
Bucci P, Mucci A, van Rossum IW, Aiello C, Arango C, Baandrup L, Buchanan RW, Dazzan P, Demjaha A, Díaz-Caneja CM, Giordano GM, Glenthøj BY, Leucht S, McGuire P, Rodriguez-Jimenez R, ... ... Kahn RS, et al. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32291210 DOI: 10.1016/J.Euroneuro.2020.03.010 |
0.328 |
|
2020 |
Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, Lind PA, Pizzagalli F, Ching CRK, McMahon MAB, Shatokhina N, Zsembik LCP, Thomopoulos SI, Zhu AH, Strike LT, ... ... Kahn RS, et al. The genetic architecture of the human cerebral cortex. Science (New York, N.Y.). 367. PMID 32193296 DOI: 10.1126/Science.Aay6690 |
0.545 |
|
2020 |
Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, Busatto GF, et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain : a Journal of Neurology. PMID 32103250 DOI: 10.1093/Brain/Awaa025 |
0.344 |
|
2020 |
van Leeuwen JMC, Vinkers CH, Vink M, Kahn RS, Joëls M, Hermans EJ. Disrupted upregulation of salience network connectivity during acute stress in siblings of schizophrenia patients. Psychological Medicine. 1-11. PMID 31941558 DOI: 10.1017/S0033291719004033 |
0.735 |
|
2020 |
Zwarte SMCd, Brouwer RRM, Kahn RS, Turner JA, Erp TGMv, Andreasen OA, Ching CRK, Jahanshad N, Thompson PM, Haren NV, Relatives E. M166. The Effect Of Intelligence And Educational Attainment On The Brain In Those With Familial High Risk For Schizophrenia Or Bipolar Disorder: An Enigma–Relatives Study Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.478 |
0.355 |
|
2020 |
Lehet M, Yao B, Tso IF, Kahn RS, Neggers SF, Thakkar KN. Compromised Neural Circuit Dynamics Underlying Impaired Control of Eye Movements in Schizophrenia Biological Psychiatry. 87: S375-S376. DOI: 10.1016/J.Biopsych.2020.02.961 |
0.327 |
|
2020 |
Chand G, Wolf DH, Erus G, Srinivasan D, Dwyer DB, Pomponio R, Sotiras A, Varol E, Doshi J, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Neuroanatomical Dimensional Phenotypes of Schizophrenia: Expression in Youth With Psychosis-Spectrum Symptoms and Correlation With Cognition Biological Psychiatry. 87: S119. DOI: 10.1016/J.Biopsych.2020.02.324 |
0.352 |
|
2020 |
van Leeuwen J, Vinkers C, Vink M, Kahn R, Joels M, Hermans E. Neural Temporal Dynamics of Stress in At-Risk Individuals Biological Psychiatry. 87: S89-S90. DOI: 10.1016/J.Biopsych.2020.02.250 |
0.61 |
|
2020 |
Wolf D, Chand G, Dwyer D, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Two Neuroanatomical Subtypes of Schizophrenia Defined by Multi-Site Machine Learning Biological Psychiatry. 87: S28-S29. DOI: 10.1016/J.Biopsych.2020.02.097 |
0.314 |
|
2019 |
Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, Gaspar H, Ikeda M, Benyamin B, Brown BC, Liu R, Zhou W, Guan L, Kamatani Y, Kim SW, ... ... Kahn RS, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nature Genetics. PMID 31740837 DOI: 10.1038/S41588-019-0512-X |
0.362 |
|
2019 |
Sneeboer MAM, van Mierlo HC, Stotijn E, MacIntyre DJ, Smith C, Kahn RS, Hol EM, de Witte LD. Increased number of T-lymphocytes in post-mortem brain tissue of patients with schizophrenia. Schizophrenia Research. PMID 31676171 DOI: 10.1016/J.Schres.2019.10.032 |
0.362 |
|
2019 |
Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, ... ... Kahn RS, et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. PMID 31636452 DOI: 10.1038/S41588-019-0511-Y |
0.538 |
|
2019 |
van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Reward-Related Striatal Responses Following Stress in Healthy Individuals and Patients With Bipolar Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471186 DOI: 10.1016/J.Bpsc.2019.06.014 |
0.729 |
|
2019 |
de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Aleman A, Alpert KI, Bearden CE, Bertolino A, Bois C, Bonvino A, Bramon E, Buimer EEL, Cahn W, Cannon DM, Cannon TD, ... ... Kahn RS, et al. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder. Biological Psychiatry. PMID 31443932 DOI: 10.1016/J.Biopsych.2019.03.985 |
0.567 |
|
2019 |
de Lange SC, Scholtens LH, van den Berg LH, Boks MP, Bozzali M, Cahn W, Dannlowski U, Durston S, Geuze E, van Haren NEM, Hillegers MHJ, Koch K, Jurado MÁ, Mancini M, ... ... Kahn RS, et al. Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders. Nature Human Behaviour. PMID 31384023 DOI: 10.1038/S41562-019-0659-6 |
0.312 |
|
2019 |
Berdenis van Berlekom A, Muflihah CH, Snijders GJLJ, MacGillavry HD, Middeldorp J, Hol EM, Kahn RS, de Witte LD. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies. Schizophrenia Bulletin. PMID 31192350 DOI: 10.1093/Schbul/Sbz060 |
0.317 |
|
2019 |
Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, ... ... Kahn RS, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics. PMID 31043756 DOI: 10.1038/S41588-019-0397-8 |
0.301 |
|
2019 |
Bossong MG, van Hell HH, Schubart CD, van Saane W, Iseger TA, Jager G, van Osch MJP, Jansma JM, Kahn RS, Boks MP, Ramsey NF. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30975584 DOI: 10.1016/J.Euroneuro.2019.03.010 |
0.538 |
|
2019 |
Cui LB, Wei Y, Xi YB, Griffa A, De Lange SC, Kahn RS, Yin H, Van den Heuvel MP. Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia. Schizophrenia Bulletin. PMID 30926985 DOI: 10.1093/Schbul/Sbz014 |
0.414 |
|
2019 |
Chang X, Collin G, Mandl RCW, Cahn W, Kahn RS. Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings. Neuroimage. Clinical. 101656. PMID 30660663 DOI: 10.1016/J.Nicl.2019.101656 |
0.422 |
|
2019 |
Yao B, Neggers SFW, Rolfs M, Rösler L, Thompson IA, Hopman HJ, Ghermezi L, Kahn RS, Thakkar KN. Structural thalamo-frontal hypoconnectivity is related to oculomotor corollary discharge dysfunction in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30630882 DOI: 10.1523/Jneurosci.1473-18.2019 |
0.361 |
|
2019 |
Ori A, Loohuis LO, Guintivano J, Clair DS, McQuillin A, Mill J, Sullivan P, Kahn R, Horvath S, Ophoff R. 30 Schizophrenia Is Characterized By Age- And Sex-Specific Effects On Epigenetic Aging European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.07.171 |
0.33 |
|
2019 |
Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Gur RC, Gur RE, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Busatto GF, Facorro BC, Pantelis C, et al. T195. Neuroanatomical Heterogeneity of Schizophrenia Quantified via Semi-Supervised Machine Learning Reveals Two Distinct Subtypes: Results From the PHENOM Consortium Biological Psychiatry. 85: S205-S206. DOI: 10.1016/J.Biopsych.2019.03.518 |
0.318 |
|
2019 |
Zwarte Sd, Brouwer R, Ching C, Andreassen O, Erp Tv, Turner J, Thompson P, Kahn R, Haren Nv. 21. ENIGMA-Relatives: The Association Between Familial Risk for Schizophrenia or Bipolar Disorder and Brain Abnormalities Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.035 |
0.384 |
|
2018 |
de Zwarte SMC, Brouwer RM, Tsouli A, Cahn W, Hillegers MHJ, Hulshoff Pol HE, Kahn RS, van Haren NEM. Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia. Schizophrenia Bulletin. PMID 30597053 DOI: 10.1093/Schbul/Sby182 |
0.409 |
|
2018 |
Prikken M, van der Weiden A, Baalbergen H, Hillegers MH, Kahn RS, Aarts H, van Haren NE. Spontaneous low-frequency fluctuations in the neural system for emotional perception in major psychiatric disorders: amplitude similarities and differences across frequency bands Journal of Psychiatry & Neuroscience : Jpn. 44: 1-8. PMID 30525317 DOI: 10.1503/Jpn.180049 |
0.348 |
|
2018 |
Zhang JP, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, Crespo-Facorro B, Vazquez-Bourgon J, Kane JM, Malhotra AK, Lencz T. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. The American Journal of Psychiatry. appiajp201817121363. PMID 30392411 DOI: 10.1176/Appi.Ajp.2018.17121363 |
0.375 |
|
2018 |
van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Increased responses of the reward circuitry to positive task feedback following acute stress in healthy controls but not in siblings of schizophrenia patients. Neuroimage. PMID 30243958 DOI: 10.1016/J.Neuroimage.2018.09.051 |
0.653 |
|
2018 |
Boks MP, Houtepen LC, Xu Z, He Y, Ursini G, Maihofer AX, Rajarajan P, Yu Q, Xu H, Wu Y, Wang S, Shi JP, Hulshoff Pol HE, Strengman E, Rutten BPF, ... ... Kahn RS, et al. Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia. Npj Schizophrenia. 4: 16. PMID 30131491 DOI: 10.1038/S41537-018-0058-4 |
0.338 |
|
2018 |
Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, et al. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. The Lancet. Psychiatry. PMID 30115598 DOI: 10.1016/S2215-0366(18)30252-9 |
0.377 |
|
2018 |
Fiksinski AM, Breetvelt EJ, Lee YJ, Boot E, Butcher N, Palmer L, Chow EWC, Kahn RS, Vorstman JAS, Bassett AS. Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia. Psychological Medicine. 1-8. PMID 30064532 DOI: 10.1017/S0033291718001824 |
0.371 |
|
2018 |
Schür RR, van Leeuwen JMC, Houtepen LC, Joëls M, Kahn RS, Boks MP, Vinkers CH. Glucocorticoid receptor exon 1 methylation and the cortisol stress response in health and disease. Psychoneuroendocrinology. 97: 182-189. PMID 30036796 DOI: 10.1016/J.Psyneuen.2018.07.018 |
0.576 |
|
2018 |
Bilderbeck AC, Penninx BWJH, Arango C, van der Wee N, Kahn R, Winter-van Rossum I, Hayen A, Kas MJ, Post A, Dawson GR. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neuroscience and Biobehavioral Reviews. PMID 29940238 DOI: 10.1016/J.Neubiorev.2018.06.019 |
0.577 |
|
2018 |
Egerton A, Broberg BV, Van Haren N, Merritt K, Barker GJ, Lythgoe DJ, Perez-Iglesias R, Baandrup L, Düring SW, Sendt KV, Stone JM, Rostrup E, Sommer IE, Glenthøj B, Kahn RS, et al. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre H-MRS study (OPTiMiSE). Molecular Psychiatry. PMID 29880882 DOI: 10.1038/S41380-018-0082-9 |
0.376 |
|
2018 |
Vorstman JAS, Olde Loohuis LM, Kahn RS, Ophoff RA. Double Hits in Schizophrenia. Human Molecular Genetics. PMID 29767709 DOI: 10.1093/Hmg/Ddy175 |
0.358 |
|
2018 |
Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, Yang HT, Wu T, Boks MP, Lomen-Hoerth C, Wiedau-Pazos M, Cantor RM, de Vos WM, Kahn RS, Eskin E, Ophoff RA. Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. Translational Psychiatry. 8: 96. PMID 29743478 DOI: 10.1038/S41398-018-0107-9 |
0.385 |
|
2018 |
van Leeuwen JMC, Vink M, Fernández G, Hermans EJ, Joëls M, Kahn RS, Vinkers CH. At-risk individuals display altered brain activity following stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29483659 DOI: 10.1038/S41386-018-0026-8 |
0.673 |
|
2018 |
Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD. Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients. Schizophrenia Research. PMID 29478863 DOI: 10.1016/J.Schres.2018.02.012 |
0.355 |
|
2018 |
van Haren N, Nikita S, Koevoets M, Baalbergen H, Vink M, Mesman E, Kahn R, Hillegers M. F17. DIFFERENCES IN INTRACRANIAL VOLUME, IQ AND PSYCHOPATHOLOGY IN YOUNG OFFSPRING OF PATIENTS AFFECTED WITH SCHIZOPHRENIA OR BIPOLAR DISORDER Schizophrenia Bulletin. 44: S225-S225. DOI: 10.1093/Schbul/Sby017.548 |
0.677 |
|
2018 |
Boks M, Houtepen L, Xu Z, He Y, Ursini G, Maihofer A, Rajarajan P, Hulshoff Pol H, Rutten B, Jaffe AE, Kleinmann JE, Baker D, Hol E, Akbarian S, Nievergelt C, ... ... Kahn R, et al. O4.1. GENETIC VULNERABILITY TO DUSP22 PROMOTOR HYPERMETHYLATION IS INVOLVED IN THE RELATION BETWEEN IN UTERO FAMINE EXPOSURE AND SCHIZOPHRENIA Schizophrenia Bulletin. 44: S82-S82. DOI: 10.1093/Schbul/Sby015.207 |
0.349 |
|
2018 |
Dazzan P, Reinders AS, Shatzi V, Carletti F, Arango C, Fleischhacker W, Galderisi S, Mucci A, Glenthoj B, Egerton A, Barker G, Leucht S, Meyer-Lindenberg A, Kahn RS, Rujescu D, et al. 31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS Schizophrenia Bulletin. 44: S50-S51. DOI: 10.1093/Schbul/Sby014.129 |
0.331 |
|
2018 |
van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. F228. Functional Activation Abnormalities Following Stress in At-Risk Individuals Biological Psychiatry. 83: S327. DOI: 10.1016/J.Biopsych.2018.02.842 |
0.619 |
|
2018 |
de Zwarte S, Brouwer R, Tsouli A, Cahn W, Hillegers M, Pol HH, Kahn R, van Haren N. F221. Brain Abnormalities and Cognitive Deficits in First-Degree Relatives of Patients With Schizophrenia Biological Psychiatry. 83: S325. DOI: 10.1016/J.Biopsych.2018.02.835 |
0.384 |
|
2018 |
Fiksinski A, Breetvelt E, Vorstman J, Lee E, Boot E, Butcher N, Palmer L, Chow E, Kahn R, Bassett A. F207. Neurocognition and Adaptive Functioning in the 22q11.2 Deletion Syndrome Model of Schizophrenia Biological Psychiatry. 83: S319. DOI: 10.1016/J.Biopsych.2018.02.821 |
0.321 |
|
2017 |
Blakey R, Ranlund S, Zartaloudi E, Cahn W, Calafato S, Colizzi M, Crespo-Facorro B, Daniel C, Díez-Revuelta Á, Di Forti M, Iyegbe C, Jablensky A, Jones R, Hall MH, ... Kahn R, et al. Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 1-20. PMID 29094675 DOI: 10.1017/S0033291717002860 |
0.303 |
|
2017 |
Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, ... ... Kahn RS, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. PMID 29038599 DOI: 10.1038/Mp.2017.170 |
0.425 |
|
2017 |
Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, ... Kahn RS, et al. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophrenia Research. PMID 28982554 DOI: 10.1016/J.Schres.2017.09.024 |
0.374 |
|
2017 |
Marsman A, Mandl RCW, Klomp DWJ, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. Intelligence and Brain Efficiency: Investigating the Association between Working Memory Performance, Glutamate, and GABA. Frontiers in Psychiatry. 8: 154. PMID 28966597 DOI: 10.3389/Fpsyt.2017.00154 |
0.301 |
|
2017 |
van Mierlo HC, Wichers CGK, He Y, Sneeboer MAM, Radstake TRDJ, Kahn RS, Broen JCA, de Witte LD. Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia. Journal of Psychiatric Research. 95: 231-234. PMID 28910708 DOI: 10.1016/J.Jpsychires.2017.09.006 |
0.395 |
|
2017 |
Collin G, Scholtens LH, Kahn RS, Hillegers MHJ, van den Heuvel MP. Affected Anatomical Rich Club and Structural-Functional Coupling in Young Offspring of Schizophrenia and Bipolar Disorder Patients. Biological Psychiatry. PMID 28734460 DOI: 10.1016/J.Biopsych.2017.06.013 |
0.377 |
|
2017 |
Witt SH, Streit F, Jungkunz M, Frank J, Awasthi S, Reinbold CS, Treutlein J, Degenhardt F, Forstner AJ, Heilmann-Heimbach S, Dietl L, Schwarze CE, Schendel D, Strohmaier J, Abdellaoui A, ... ... Kahn RS, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Translational Psychiatry. 7: e1155. PMID 28632202 DOI: 10.1038/Tp.2017.115 |
0.322 |
|
2017 |
Wei Y, Collin G, Mandl RCW, Cahn W, Keunen K, Schmidt R, Kahn RS, van den Heuvel MP. Cortical magnetization transfer abnormalities and connectome dysconnectivity in schizophrenia. Schizophrenia Research. PMID 28601503 DOI: 10.1016/J.Schres.2017.05.029 |
0.403 |
|
2017 |
Brouwer RM, Panizzon MS, Glahn DC, Hibar DP, Hua X, Jahanshad N, Abramovic L, de Zubicaray GI, Franz CE, Hansell NK, Hickie IB, Koenis MMG, Martin NG, Mather KA, McMahon KL, ... ... Kahn RS, et al. Genetic influences on individual differences in longitudinal changes in global and subcortical brain volumes: Results of the ENIGMA plasticity working group. Human Brain Mapping. PMID 28580697 DOI: 10.1002/Hbm.23672 |
0.305 |
|
2017 |
Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 1-13. PMID 28545597 DOI: 10.1017/S0033291717001283 |
0.408 |
|
2017 |
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, ... ... Kahn RS, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry. PMID 28461699 DOI: 10.1038/Mp.2017.73 |
0.366 |
|
2017 |
de With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA. More than 25 years of genetic studies of clozapine-induced agranulocytosis. The Pharmacogenomics Journal. PMID 28418011 DOI: 10.1038/Tpj.2017.6 |
0.642 |
|
2017 |
Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. PMID 28369804 DOI: 10.1111/Acps.12718 |
0.356 |
|
2017 |
Keefe RS, Kahn RS. Cognitive Decline and Disrupted Cognitive Trajectory in Schizophrenia. Jama Psychiatry. PMID 28329400 DOI: 10.1001/Jamapsychiatry.2017.0312 |
0.308 |
|
2017 |
McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications. 8: 14774. PMID 28322246 DOI: 10.1038/Ncomms14774 |
0.371 |
|
2017 |
Chang X, Collin G, Xi Y, Cui L, Scholtens LH, Sommer IE, Wang H, Yin H, Kahn RS, van den Heuvel MP. Resting-state functional connectivity in medication-naïve schizophrenia patients with and without auditory verbal hallucinations: A preliminary report. Schizophrenia Research. PMID 28130005 DOI: 10.1016/J.Schres.2017.01.024 |
0.405 |
|
2017 |
Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, ... ... Kahn RS, et al. Novel genetic loci associated with hippocampal volume. Nature Communications. 8: 13624. PMID 28098162 DOI: 10.1038/Ncomms13624 |
0.754 |
|
2017 |
Egerton A, Merritt K, McQueen G, Howes O, Demjaha A, Brugger S, Barker G, Stone J, Dazzan P, Broberg B, van Haren N, Glenthoj B, Kahn R, McGuire P. SA83. Brain Glutamate Levels and Antipsychotic Response in Schizophrenia Schizophrenia Bulletin. 43: S142-S143. DOI: 10.1093/Schbul/Sbx023.081 |
0.377 |
|
2017 |
Collin G, Hillegers M, Scholtens L, Kahn R, van den Heuvel M. 166. Affected Anatomical Rich Club Core and Structural–Functional Integration in Young Offspring of Schizophrenia and Bipolar Disorder Patients Schizophrenia Bulletin. 43: S84-S84. DOI: 10.1093/Schbul/Sbx021.224 |
0.379 |
|
2017 |
Van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. The dynamic brain response to stress is impaired in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S548. DOI: 10.1016/S0924-977X(17)31047-7 |
0.684 |
|
2017 |
Van Leeuwen J, Vink M, Joëls M, Kahn R, Vinkers C. Psychosocial stress and emotion processing in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S76. DOI: 10.1016/S0924-977X(16)31211-1 |
0.666 |
|
2017 |
Zwarte Sd, Brouwer R, Hillegers M, Cahn W, Pol HH, Kahn R, Alpert K, Wang L, Bramon E, Kane F, Murray R, Hajek T, Alda M, Roberts G, Mitchell P, et al. 278. ENIGMA-Relatives – Brain Volumes in First-Degree Relatives of Schizophrenia and Bipolar Patients Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.292 |
0.418 |
|
2016 |
Prikken M, van der Weiden A, Renes RA, Koevoets MG, Heering HD, Kahn RS, Aarts H, van Haren NE. Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk. Psychiatry Research. 250: 270-276. PMID 28189096 DOI: 10.1016/J.Psychres.2016.10.077 |
0.358 |
|
2016 |
Zorn JV, Schür RR, Boks MP, Kahn RS, Joëls M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 77: 25-36. PMID 28012291 DOI: 10.1016/J.Psyneuen.2016.11.036 |
0.583 |
|
2016 |
de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 40: 38-44. PMID 27837671 DOI: 10.1016/J.Eurpsy.2016.06.011 |
0.548 |
|
2016 |
Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, ... ... Kahn RS, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nature Neuroscience. PMID 27694991 DOI: 10.1038/Nn.4398 |
0.736 |
|
2016 |
Schür RR, Boks MP, Geuze E, Prinsen HC, Verhoeven-Duif NM, Joëls M, Kahn RS, Vermetten E, Vinkers CH. Development of psychopathology in deployed armed forces in relation to plasma GABA levels. Psychoneuroendocrinology. 73: 263-270. PMID 27566489 DOI: 10.1016/J.Psyneuen.2016.08.014 |
0.554 |
|
2016 |
Collin G, Kahn RS. Schizophrenia in the Era of Brain Complexity. The Journal of Nervous and Mental Disease. 204: 561-3. PMID 27479610 DOI: 10.1097/Nmd.0000000000000545 |
0.376 |
|
2016 |
de Leeuw M, Bohlken MM, Mandl RC, Hillegers MH, Kahn RS, Vink M. Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27440007 DOI: 10.1038/Npp.2016.130 |
0.692 |
|
2016 |
Thakkar KN, Rösler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, Kahn RS, Neggers SF. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings. Biological Psychiatry. PMID 27316853 DOI: 10.1016/J.Biopsych.2016.04.007 |
0.344 |
|
2016 |
Bootsman F, Brouwer RM, Schnack HG, Kemner SM, Hillegers MH, Sarkisyan G, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. A study of genetic and environmental contributions to structural brain changes over time in twins concordant and discordant for bipolar disorder. Journal of Psychiatric Research. 79: 116-124. PMID 27218817 DOI: 10.1016/J.Jpsychires.2016.04.011 |
0.361 |
|
2016 |
Schür RR, Draisma LW, Wijnen JP, Boks MP, Koevoets MG, Joëls M, Klomp DW, Kahn RS, Vinkers CH. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies. Human Brain Mapping. PMID 27145016 DOI: 10.1002/Hbm.23244 |
0.606 |
|
2016 |
Thakkar KN, van den Heiligenberg FM, Kahn RS, Neggers SF. Speed of saccade execution and inhibition associated with fractional anisotropy in distinct fronto-frontal and fronto-striatal white matter pathways. Human Brain Mapping. PMID 27091670 DOI: 10.1002/Hbm.23209 |
0.353 |
|
2016 |
Gifford G, Crossley N, Fusar-Poli P, Schnack HG, Kahn RS, Koutsouleris N, Cannon TD, McGuire P. Using neuroimaging to help predict the onset of psychosis. Neuroimage. PMID 27039698 DOI: 10.1016/J.Neuroimage.2016.03.075 |
0.464 |
|
2016 |
Houtepen LC, Vinkers CH, Carrillo-Roa T, Hiemstra M, van Lier PA, Meeus W, Branje S, Heim CM, Nemeroff CB, Mill J, Schalkwyk LC, Creyghton MP, Kahn RS, Joëls M, Binder EB, et al. Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans. Nature Communications. 7: 10967. PMID 26997371 DOI: 10.1038/Ncomms10967 |
0.56 |
|
2016 |
Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, et al. Altering the course of schizophrenia: progress and perspectives. Nature Reviews. Drug Discovery. PMID 26939910 DOI: 10.1038/Nrd.2016.28 |
0.389 |
|
2016 |
Kleerekooper I, van Rooij SJ, van den Wildenberg WP, de Leeuw M, Kahn RS, Vink M. The effect of aging on fronto-striatal reactive and proactive inhibitory control. Neuroimage. PMID 26899783 DOI: 10.1016/J.Neuroimage.2016.02.031 |
0.641 |
|
2016 |
Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, Haukvik UK, Hartberg CB, Doan NT, Agartz I, Dale AM, Gruber O, Krämer B, Trost S, Liberg B, ... ... Kahn RS, et al. Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry. PMID 26857596 DOI: 10.1038/Mp.2015.227 |
0.345 |
|
2016 |
Collin G, Hilligers MHJ, Scholtens LH, Kahn RS, Heuvel MPVd. Rich club organization of the connectome in children at familial high risk for schizophrenia and bipolar disorder European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31552-8 |
0.334 |
|
2015 |
de Leeuw M, Bohlken MM, Mandl RC, Kahn RS, Vink M. Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study. Npj Schizophrenia. 1: 15001. PMID 27336028 DOI: 10.1038/npjschz.2015.1 |
0.668 |
|
2015 |
Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, O'Donovan M, Correll CU, Kane JM, van Os J, Insel TR. Schizophrenia. Nature Reviews. Disease Primers. 1: 15067. PMID 27189524 DOI: 10.1038/nrdp.2015.67 |
0.493 |
|
2015 |
Renes RA, Vink M, van der Weiden A, Prikken M, Koevoets MG, Kahn RS, Aarts H, van Haren NE. Impaired frontal processing during agency inferences in schizophrenia. Psychiatry Research. PMID 26776080 DOI: 10.1016/J.Pscychresns.2015.12.006 |
0.695 |
|
2015 |
Vink M, de Leeuw M, Pouwels R, van den Munkhof HE, Kahn RS, Hillegers M. Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients. Schizophrenia Research. PMID 26631365 DOI: 10.1016/J.Schres.2015.11.018 |
0.693 |
|
2015 |
Vink M, de Leeuw M, Luykx JJ, van Eijk KR, van den Munkhof HE, van Buuren M, Kahn RS. DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients. Schizophrenia Bulletin. PMID 26598739 DOI: 10.1093/Schbul/Sbv166 |
0.679 |
|
2015 |
Bootsman F, Brouwer RM, Kemner SM, Schnack HG, van der Schot AC, Vonk R, Hillegers MH, Boomsma DI, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Contribution of genes and unique environment to cross-sectional and longitudinal measures of subcortical volumes in bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26481908 DOI: 10.1016/J.Euroneuro.2015.09.023 |
0.338 |
|
2015 |
Collin G, van den Heuvel MP, Abramovic L, Vreeker A, de Reus MA, van Haren NE, Boks MP, Ophoff RA, Kahn RS. Brain network analysis reveals affected connectome structure in bipolar I disorder. Human Brain Mapping. PMID 26454006 DOI: 10.1002/Hbm.23017 |
0.358 |
|
2015 |
Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, ... ... Kahn RS, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. PMID 26286434 DOI: 10.1093/Ije/Dyv136 |
0.335 |
|
2015 |
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26283641 DOI: 10.1038/Mp.2015.118 |
0.67 |
|
2015 |
Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 26283640 DOI: 10.1038/Mp.2015.117 |
0.519 |
|
2015 |
Emsley R, Asmal L, Chiliza B, du Plessis S, Carr J, Kidd M, Malhotra AK, Vink M, Kahn RS. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia. Psychiatry Research. PMID 26184461 DOI: 10.1016/J.Pscychresns.2015.06.014 |
0.668 |
|
2015 |
Rösler L, Rolfs M, Van der Stigchel S, Neggers SF, Cahn W, Kahn RS, Thakkar KN. Failure to use corollary discharge to remap visual target locations is associated with psychotic symptom severity in schizophrenia. Journal of Neurophysiology. jn.00155.2015. PMID 26108951 DOI: 10.1152/Jn.00155.2015 |
0.311 |
|
2015 |
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26033243 DOI: 10.1038/Mp.2015.63 |
0.669 |
|
2015 |
Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J. Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1158-66. PMID 26004980 DOI: 10.1016/J.Euroneuro.2015.04.003 |
0.359 |
|
2015 |
Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 808-16. PMID 25907250 DOI: 10.1016/J.Euroneuro.2015.02.012 |
0.385 |
|
2015 |
Arango C, Kapur S, Kahn RS. Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia. Schizophrenia Bulletin. 41: 546-8. PMID 25864201 DOI: 10.1093/Schbul/Sbv026 |
0.341 |
|
2015 |
Renes RA, van der Weiden A, Prikken M, Kahn RS, Aarts H, van Haren NE. Abnormalities in the experience of self-agency in schizophrenia: A replication study. Schizophrenia Research. 164: 210-3. PMID 25843918 DOI: 10.1016/J.Schres.2015.03.015 |
0.33 |
|
2015 |
Bossong MG, Mehta MA, van Berckel BN, Howes OD, Kahn RS, Stokes PR. Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology. 232: 2723-9. PMID 25801289 DOI: 10.1007/S00213-015-3915-0 |
0.336 |
|
2015 |
Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophrenia Bulletin. 41: 574-83. PMID 25800248 DOI: 10.1093/Schbul/Sbv024 |
0.348 |
|
2015 |
Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, ... ... Kahn RS, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. Jama Psychiatry. 72: 377-85. PMID 25715178 DOI: 10.1001/Jamapsychiatry.2014.2671 |
0.312 |
|
2015 |
Vink M, Kleerekooper I, van den Wildenberg WP, Kahn RS. Impact of aging on frontostriatal reward processing. Human Brain Mapping. 36: 2305-17. PMID 25704624 DOI: 10.1002/Hbm.22771 |
0.642 |
|
2015 |
Vinkers CH, Joëls M, Milaneschi Y, Gerritsen L, Kahn RS, Penninx BW, Boks MP. Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment. Psychoneuroendocrinology. 54: 90-102. PMID 25686805 DOI: 10.1016/J.Psyneuen.2015.01.018 |
0.556 |
|
2015 |
Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, Aribisala BS, Armstrong NJ, Bernard M, Bohlken MM, Boks MP, ... ... Kahn RS, et al. Common genetic variants influence human subcortical brain structures. Nature. 520: 224-9. PMID 25607358 DOI: 10.1038/Nature14101 |
0.684 |
|
2015 |
Maat A, van Montfort SJ, de Nijs J, Derks EM, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Emotion processing in schizophrenia is state and trait dependent. Schizophrenia Research. 161: 392-8. PMID 25543332 DOI: 10.1016/J.Schres.2014.11.027 |
0.36 |
|
2015 |
Mandl RC, Pasternak O, Cahn W, Kubicki M, Kahn RS, Shenton ME, Hulshoff Pol HE. Comparing free water imaging and magnetization transfer measurements in schizophrenia. Schizophrenia Research. 161: 126-32. PMID 25454797 DOI: 10.1016/J.Schres.2014.09.046 |
0.34 |
|
2015 |
Houtepen LC, Boks MP, Kahn RS, Joëls M, Vinkers CH. Antipsychotic use is associated with a blunted cortisol stress response: a study in euthymic bipolar disorder patients and their unaffected siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 77-84. PMID 25453485 DOI: 10.1016/J.Euroneuro.2014.10.005 |
0.594 |
|
2015 |
de Leeuw M, Kahn RS, Vink M. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 41: 94-103. PMID 25368371 DOI: 10.1093/Schbul/Sbu153 |
0.718 |
|
2015 |
Bootsman F, Brouwer RM, Schnack HG, van Baal GC, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Genetic and environmental influences on cortical surface area and cortical thickness in bipolar disorder. Psychological Medicine. 45: 193-204. PMID 25065711 DOI: 10.1017/S0033291714001251 |
0.303 |
|
2015 |
van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Neural correlates of trauma-unrelated emotional processing in war veterans with PTSD. Psychological Medicine. 45: 575-87. PMID 25036523 DOI: 10.1017/S0033291714001706 |
0.598 |
|
2015 |
Hillegers M, De Jong A, Vink M, Pouwels R, Vleeschouwer M, Van Haren N, Kahn R. S.22.01 Clinical and neuro-imaging characteristics of child and adolescent bipolar and schizophrenia offspring European Neuropsychopharmacology. 25: S142. DOI: 10.1016/S0924-977X(15)30101-2 |
0.658 |
|
2015 |
Pijnenborg G, Timmerman M, Derks E, Fleischhacker W, Kahn R, Aleman A. Do Antipsychotics Affect Insight in Psychosis Differentially? Data From the EUFEST Trial. European Psychiatry. 30: 239. DOI: 10.1016/S0924-9338(15)30194-2 |
0.388 |
|
2014 |
Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Dermatoglyphics in relation to brain volumes in twins concordant and discordant for bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1885-95. PMID 25451699 DOI: 10.1016/J.Euroneuro.2014.09.010 |
0.33 |
|
2014 |
Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 25450228 DOI: 10.1038/Mp.2014.152 |
0.547 |
|
2014 |
Marsman A, Mandl RC, Klomp DW, Bohlken MM, Boer VO, Andreychenko A, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study. Neuroimage. Clinical. 6: 398-407. PMID 25379453 DOI: 10.1016/J.Nicl.2014.10.005 |
0.348 |
|
2014 |
Stringer S, Kahn RS, de Witte LD, Ophoff RA, Derks EM. Genetic liability for schizophrenia predicts risk of immune disorders. Schizophrenia Research. 159: 347-52. PMID 25266548 DOI: 10.1016/J.Schres.2014.09.004 |
0.353 |
|
2014 |
van Lutterveld R, van den Heuvel MP, Diederen KM, de Weijer AD, Begemann MJ, Brouwer RM, Daalman K, Blom JD, Kahn RS, Sommer IE. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain : a Journal of Neurology. 137: 2664-9. PMID 24951640 DOI: 10.1093/Brain/Awu167 |
0.327 |
|
2014 |
van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Impaired right inferior frontal gyrus response to contextual cues in male veterans with PTSD during response inhibition. Journal of Psychiatry & Neuroscience : Jpn. 39: 330-8. PMID 24886789 DOI: 10.1503/Jpn.130223 |
0.636 |
|
2014 |
Marques TR, Levine SZ, Reichenberg A, Kahn R, Derks EM, Fleischhacker WW, Rabinowitz J, Kapur S. How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1279-88. PMID 24862257 DOI: 10.1016/J.Euroneuro.2014.04.001 |
0.367 |
|
2014 |
Brouwer RM, Hedman AM, van Haren NE, Schnack HG, Brans RG, Smit DJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of brain volume change and its relation to intelligence. Neuroimage. 100: 676-83. PMID 24816534 DOI: 10.1016/J.Neuroimage.2014.04.072 |
0.308 |
|
2014 |
Vinkers CH, Joëls M, Milaneschi Y, Kahn RS, Penninx BW, Boks MP. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depression and Anxiety. 31: 737-45. PMID 24753162 DOI: 10.1002/Da.22262 |
0.547 |
|
2014 |
de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154: 23-9. PMID 24582037 DOI: 10.1016/J.Schres.2014.02.005 |
0.333 |
|
2014 |
Vink M, Zandbelt BB, Gladwin T, Hillegers M, Hoogendam JM, van den Wildenberg WP, Du Plessis S, Kahn RS. Frontostriatal activity and connectivity increase during proactive inhibition across adolescence and early adulthood. Human Brain Mapping. 35: 4415-27. PMID 24532023 DOI: 10.1002/Hbm.22483 |
0.801 |
|
2014 |
Vink M, Derks JM, Hoogendam JM, Hillegers M, Kahn RS. Functional differences in emotion processing during adolescence and early adulthood. Neuroimage. 91: 70-6. PMID 24468408 DOI: 10.1016/J.Neuroimage.2014.01.035 |
0.648 |
|
2014 |
Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 575-84. PMID 24418213 DOI: 10.1016/J.Euroneuro.2013.12.009 |
0.302 |
|
2014 |
Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, ... ... Kahn RS, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging and Behavior. 8: 153-82. PMID 24399358 DOI: 10.1007/S11682-013-9269-5 |
0.769 |
|
2014 |
Collin G, Kahn RS, de Reus MA, Cahn W, van den Heuvel MP. Impaired rich club connectivity in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 40: 438-48. PMID 24298172 DOI: 10.1093/Schbul/Sbt162 |
0.429 |
|
2014 |
Bohlken MM, Brouwer RM, Mandl RC, van Haren NE, Brans RG, van Baal GC, de Geus EJ, Boomsma DI, Kahn RS, Hulshoff Pol HE. Genes contributing to subcortical volumes and intellectual ability implicate the thalamus. Human Brain Mapping. 35: 2632-42. PMID 24038793 DOI: 10.1002/Hbm.22356 |
0.321 |
|
2014 |
Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, ... ... Kahn RS, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97. PMID 23871474 DOI: 10.1016/J.Biopsych.2013.03.033 |
0.372 |
|
2014 |
Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, DeYoung J, de Jong S, Sul JH, Eskin E, van Eijk K, van Setten J, Buizer-Voskamp JE, Cantor RM, Lu A, ... ... Kahn RS, et al. Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Molecular Psychiatry. 19: 228-34. PMID 23319000 DOI: 10.1038/Mp.2012.183 |
0.309 |
|
2014 |
De Leeuw M, Bohlken M, Mandl R, Kahn R, Vink M. P.3.b.022 Fronto–striatal pathways among schizophrenia patients and their unaffected siblings European Neuropsychopharmacology. 24: S504. DOI: 10.1016/S0924-977X(14)70806-5 |
0.672 |
|
2014 |
Bossong M, Schubart C, Van Hell H, Iseger T, Van Saane W, Jager G, Van Osch P, Jansma J, Kahn R, Boks M, Ramsey N. P.1.i.012 Genetic modulation of acute effects of delta-9-tetrahydrocannabinol (THC) on resting state brain function European Neuropsychopharmacology. 24: S303-S304. DOI: 10.1016/S0924-977X(14)70481-X |
0.498 |
|
2014 |
van Rooij S, Rademaker A, Kennis M, Vink M, Kahn R, Geuze E. P.4.001 Neural correlates of non-trauma related emotional processing in war veterans with posttraumatic stress disorder European Neuropsychopharmacology. 24: S81. DOI: 10.1016/S0924-977X(14)70091-4 |
0.617 |
|
2014 |
Emsley R, Asmal L, Ciliza B, Plessis Sd, Carr J, Kidd M, Vink M, Kahn R. Poster #T68 BRAIN SYSTEMS REGULATING FOOD-INTAKE AND BODY MASS CHANGES DURING ACUTE ANTIPSYCHOTIC TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70885-0 |
0.656 |
|
2014 |
Vink M, Pouwels R, Hillegers M, Kahn R. Poster #M72 DIFFERENTIAL DEVELOPMENT OF THE REWARD NETWORK IN ADOLESCENT OFFSPRING OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 153: S215-S216. DOI: 10.1016/S0920-9964(14)70622-X |
0.662 |
|
2014 |
Pouwels R, Kahn R, Hillegers M, Vink M. Poster #S106 IMPAIRED DEVELOPMENT OF BRAIN ACTIVATION UNDERLYING AFFECTIVE PROCESSING IN ADOLESCENTS AT FAMILIAL RISK FOR BIPOLAR DISORDER OR SCHIZOPHRENIA Schizophrenia Research. 153: S127. DOI: 10.1016/S0920-9964(14)70385-8 |
0.68 |
|
2014 |
Williams JB, Kane JM, Kahn RS. SCHIZOPHRENIA RESEARCH: THE CHALLENGE OF MEASUREMENT VARIABILITY Schizophrenia Research. 153: S86. DOI: 10.1016/S0920-9964(14)70275-0 |
0.345 |
|
2014 |
de Leeuw M, Kahn R, Vink M. 5:30 PM REWARD PROCESSING IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 153: S64. DOI: 10.1016/S0920-9964(14)70206-3 |
0.689 |
|
2014 |
Marsman A, Mandl R, Klomp D, Bohlken M, Boer V, Andreychenko A, Cahn W, Kahn R, Luijten P, Pol HH. 5:15 Pm Gaba And Glutamate In Schizophrenia: A 7T 1H-Mrs Study Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70179-3 |
0.309 |
|
2014 |
Heuvel Mvd, Collin G, Hillegers M, Reus Md, Kahn W, Kahn R. 5:00 Pm Emerging Evidence Of Affected Anatomical Rich Club Hub Structure In Schizophrenia Patients, Their Healthy Siblings And Their Non-Affected Young Offspring Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70178-1 |
0.404 |
|
2014 |
Kahn RS, Vink M, Hillegers M, Vleeschouwer M. ABNORMALITIES IN REWARD PROCESSING IN OFFSPRING OF SCHIZOPHRENIA PATIENTS: FRONTAL-STRIATAL ABNORMALITIES AS A HIGH-RISK PHENOTYPE Schizophrenia Research. 153: S38. DOI: 10.1016/S0920-9964(14)70125-2 |
0.684 |
|
2014 |
Siever LJ, Kahn RS. NEW VISTAS IN DOPAMINE RECEPTOR RESEARCH: IMPLICATIONS FOR NOVEL THERAPIES IN SCHIZOPHRENIA Schizophrenia Research. 153: S5. DOI: 10.1016/S0920-9964(14)70016-7 |
0.327 |
|
2014 |
Kahn R. Social neuroscience in psychiatry: Of obvious relevance World Psychiatry. 13: 147-148. DOI: 10.1002/Wps.20124 |
0.38 |
|
2013 |
Jansma JM, van Raalten TR, Boessen R, Neggers SF, Jacobs RH, Kahn RS, Ramsey NF. fMRI guided rTMS evidence for reduced left prefrontal involvement after task practice. Plos One. 8: e80256. PMID 24376494 DOI: 10.1371/Journal.Pone.0080256 |
0.529 |
|
2013 |
Hoogendam JM, Kahn RS, Hillegers MH, van Buuren M, Vink M. Different developmental trajectories for anticipation and receipt of reward during adolescence. Developmental Cognitive Neuroscience. 6: 113-24. PMID 24055865 DOI: 10.1016/J.Dcn.2013.08.004 |
0.635 |
|
2013 |
de Leeuw M, Kahn RS, Zandbelt BB, Widschwendter CG, Vink M. Working memory and default mode network abnormalities in unaffected siblings of schizophrenia patients. Schizophrenia Research. 150: 555-62. PMID 24051015 DOI: 10.1016/J.Schres.2013.08.016 |
0.813 |
|
2013 |
Bossong MG, Jansma JM, van Hell HH, Jager G, Kahn RS, Ramsey NF. Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function. Plos One. 8: e70074. PMID 23936144 DOI: 10.1371/Journal.Pone.0070074 |
0.561 |
|
2013 |
Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, ... ... Kahn RS, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics. 45: 984-94. PMID 23933821 DOI: 10.1038/Ng.2711 |
0.308 |
|
2013 |
Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1687-97. PMID 23928295 DOI: 10.1016/J.Euroneuro.2013.06.009 |
0.515 |
|
2013 |
Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. Jama Psychiatry. 70: 1107-12. PMID 23925787 DOI: 10.1001/Jamapsychiatry.2013.155 |
0.349 |
|
2013 |
Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS. NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies. Neuroscience and Biobehavioral Reviews. 37: 1587-96. PMID 23792047 DOI: 10.1016/J.Neubiorev.2013.06.007 |
0.321 |
|
2013 |
van den Heuvel MP, Sporns O, Collin G, Scheewe T, Mandl RC, Cahn W, Goñi J, Hulshoff Pol HE, Kahn RS. Abnormal rich club organization and functional brain dynamics in schizophrenia. Jama Psychiatry. 70: 783-92. PMID 23739835 DOI: 10.1001/Jamapsychiatry.2013.1328 |
0.391 |
|
2013 |
Jansma JM, van Hell HH, Vanderschuren LJ, Bossong MG, Jager G, Kahn RS, Ramsey NF. THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. Translational Psychiatry. 3: e234. PMID 23443360 DOI: 10.1038/Tp.2013.6 |
0.5 |
|
2013 |
Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 33: 258-61. PMID 23422388 DOI: 10.1097/Jcp.0B013E3182856886 |
0.366 |
|
2013 |
van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn W, Ripke S, Ophoff RA, Kahn RS. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine. 43: 2563-70. PMID 23410598 DOI: 10.1017/S0033291713000196 |
0.399 |
|
2013 |
Terwisscha van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ. Fibroblast growth factors in neurodevelopment and psychopathology. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 19: 479-94. PMID 23343917 DOI: 10.1177/1073858412472399 |
0.312 |
|
2013 |
Diederen KM, Neggers SF, de Weijer AD, van Lutterveld R, Daalman K, Eickhoff SB, Clos M, Kahn RS, Sommer IE. Aberrant resting-state connectivity in non-psychotic individuals with auditory hallucinations. Psychological Medicine. 43: 1685-96. PMID 23199762 DOI: 10.1017/S0033291712002541 |
0.351 |
|
2013 |
Vorstman JA, Anney RJ, Derks EM, Gallagher L, Gill M, de Jonge MV, van Engeland H, Kahn RS, Ophoff RA. No evidence that common genetic risk variation is shared between schizophrenia and autism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 55-60. PMID 23193033 DOI: 10.1002/Ajmg.B.32121 |
0.376 |
|
2013 |
Renes RA, Vermeulen L, Kahn RS, Aarts H, van Haren NE. Abnormalities in the establishment of feeling of self-agency in schizophrenia. Schizophrenia Research. 143: 50-4. PMID 23178108 DOI: 10.1016/J.Schres.2012.10.024 |
0.343 |
|
2013 |
Zandbelt BB, Bloemendaal M, Hoogendam JM, Kahn RS, Vink M. Transcranial magnetic stimulation and functional MRI reveal cortical and subcortical interactions during stop-signal response inhibition. Journal of Cognitive Neuroscience. 25: 157-74. PMID 23066733 DOI: 10.1162/Jocn_A_00309 |
0.781 |
|
2013 |
Collin G, de Reus MA, Cahn W, Hulshoff Pol HE, Kahn RS, van den Heuvel MP. Disturbed grey matter coupling in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 46-54. PMID 23036782 DOI: 10.1016/J.Euroneuro.2012.09.001 |
0.394 |
|
2013 |
van den Heuvel MP, van Soelen IL, Stam CJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Genetic control of functional brain network efficiency in children. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 19-23. PMID 22819192 DOI: 10.1016/J.Euroneuro.2012.06.007 |
0.313 |
|
2013 |
van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology. 38: 155-65. PMID 22776420 DOI: 10.1016/J.Psyneuen.2012.05.015 |
0.533 |
|
2013 |
Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/J.Euroneuro.2012.04.019 |
0.353 |
|
2013 |
Zandbelt BB, Bloemendaal M, Neggers SF, Kahn RS, Vink M. Expectations and violations: delineating the neural network of proactive inhibitory control. Human Brain Mapping. 34: 2015-24. PMID 22359406 DOI: 10.1002/Hbm.22047 |
0.777 |
|
2013 |
Howes OD, Shotbolt P, Bloomfield M, Daalman K, Demjaha A, Diederen KM, Ibrahim K, Kim E, McGuire P, Kahn RS, Sommer IE. Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophrenia Bulletin. 39: 807-14. PMID 22282457 DOI: 10.1093/Schbul/Sbr195 |
0.31 |
|
2013 |
Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophrenia Bulletin. 39: 120-9. PMID 21746807 DOI: 10.1093/Schbul/Sbr069 |
0.388 |
|
2013 |
Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Poster sessionsP.1.g. Basic and clinical neuroscience – NeuropharmacologyP.1.g.024 Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70311-0 |
0.3 |
|
2013 |
De Leeuw M, Kahn R, Vink M. S.07.07 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S122. DOI: 10.1016/S0924-977X(13)70151-2 |
0.674 |
|
2013 |
de Leeuw M, Vink M, Kahn R. P.4.006 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S72-S73. DOI: 10.1016/S0924-977X(13)70081-6 |
0.613 |
|
2012 |
van Buuren M, Vink M, Kahn RS. Default-mode network dysfunction and self-referential processing in healthy siblings of schizophrenia patients. Schizophrenia Research. 142: 237-43. PMID 23099059 DOI: 10.1016/J.Schres.2012.09.017 |
0.702 |
|
2012 |
van der Kemp WJ, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophrenia Research. 141: 153-61. PMID 22981812 DOI: 10.1016/J.Schres.2012.08.014 |
0.363 |
|
2012 |
He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D. Schizophrenia shows a unique metabolomics signature in plasma Translational Psychiatry. 2. PMID 22892715 DOI: 10.1038/Tp.2012.76 |
0.39 |
|
2012 |
van Soelen IL, Brouwer RM, Peper JS, van Leeuwen M, Koenis MM, van Beijsterveldt TC, Swagerman SC, Kahn RS, Hulshoff Pol HE, Boomsma DI. Brain SCALE: brain structure and cognition: an adolescent longitudinal twin study into the genetic etiology of individual differences. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 15: 453-67. PMID 22856378 DOI: 10.1017/Thg.2012.4 |
0.309 |
|
2012 |
Geyer MA, Olivier B, Joëls M, Kahn RS. From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends in Pharmacological Sciences. 33: 515-21. PMID 22810174 DOI: 10.1016/J.Tips.2012.06.006 |
0.348 |
|
2012 |
de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, Ori AP, Vi N, Mulder F, Blom JD, Glenthøj B, Schubart CD, Cahn W, Kahn RS, Horvath S, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. Plos One. 7: e39498. PMID 22761806 DOI: 10.1371/Journal.Pone.0039498 |
0.375 |
|
2012 |
Collin G, Derks EM, van Haren NE, Schnack HG, Hulshoff Pol HE, Kahn RS, Cahn W. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophrenia Research. 138: 171-6. PMID 22534419 DOI: 10.1016/J.Schres.2012.03.036 |
0.393 |
|
2012 |
Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, ... ... Kahn RS, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics. 44: 552-61. PMID 22504417 DOI: 10.1038/Ng.2250 |
0.766 |
|
2012 |
Hulshoff Pol HE, van Baal GC, Schnack HG, Brans RG, van der Schot AC, Brouwer RM, van Haren NE, Lepage C, Collins DL, Evans AC, Boomsma DI, Nolen W, Kahn RS. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Archives of General Psychiatry. 69: 349-59. PMID 22474104 DOI: 10.1001/Archgenpsychiatry.2011.1615 |
0.418 |
|
2012 |
de Jong S, van Eijk KR, Zeegers DW, Strengman E, Janson E, Veldink JH, van den Berg LH, Cahn W, Kahn RS, Boks MP, Ophoff RA. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. European Journal of Human Genetics : Ejhg. 20: 1004-8. PMID 22433715 DOI: 10.1038/Ejhg.2012.38 |
0.376 |
|
2012 |
van Haren NE, Rijsdijk F, Schnack HG, Picchioni MM, Toulopoulou T, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Huttunen MO, Boomsma DI, Hulshoff Pol HE, Murray RM, Kahn RS. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biological Psychiatry. 71: 915-21. PMID 22341827 DOI: 10.1016/J.Biopsych.2012.01.010 |
0.717 |
|
2012 |
Bossong MG, Jansma JM, van Hell HH, Jager G, Oudman E, Saliasi E, Kahn RS, Ramsey NF. Effects of δ9-tetrahydrocannabinol on human working memory function. Biological Psychiatry. 71: 693-9. PMID 22341370 DOI: 10.1016/J.Biopsych.2012.01.008 |
0.59 |
|
2012 |
Luykx JJ, Bakker SC, Lentjes E, Boks MP, van Geloven N, Eijkemans MJ, Janson E, Strengman E, de Lepper AM, Westenberg H, Klopper KE, Hoorn HJ, Gelissen HP, Jordan J, Tolenaar NM, ... ... Kahn RS, et al. Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid. Plos One. 7: e30497. PMID 22312427 DOI: 10.1371/Journal.Pone.0030497 |
0.545 |
|
2012 |
Bossong MG, Jager G, van Hell HH, Zuurman L, Jansma JM, Mehta MA, van Gerven JM, Kahn RS, Ramsey NF. Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. Journal of Cognitive Neuroscience. 24: 588-99. PMID 22066583 DOI: 10.1162/Jocn_A_00156 |
0.527 |
|
2012 |
van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, van Gerven J, Kahn RS, Ramsey NF. Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology. 219: 981-90. PMID 21822593 DOI: 10.1007/S00213-011-2428-8 |
0.529 |
|
2012 |
Machielsen M, Beduin AS, Dekker N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology (Oxford, England). 26: 189-95. PMID 21768161 DOI: 10.1177/0269881111408957 |
0.324 |
|
2012 |
van Rijn S, Swaab H, Baas D, de Haan E, Kahn RS, Aleman A. Neural systems for social cognition in Klinefelter syndrome (47,XXY): evidence from fMRI. Social Cognitive and Affective Neuroscience. 7: 689-97. PMID 21737434 DOI: 10.1093/Scan/Nsr041 |
0.321 |
|
2012 |
Klomp A, Koolschijn PC, Hulshoff Pol HE, Kahn RS, Haren NE. Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 281-8. PMID 21733239 DOI: 10.1017/S1461145711000794 |
0.38 |
|
2012 |
van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. The course of brain abnormalities in schizophrenia: can we slow the progression? Journal of Psychopharmacology (Oxford, England). 26: 8-14. PMID 21730018 DOI: 10.1177/0269881111408964 |
0.39 |
|
2012 |
Diederen KM, Daalman K, de Weijer AD, Neggers SF, van Gastel W, Blom JD, Kahn RS, Sommer IE. Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophrenia Bulletin. 38: 1074-82. PMID 21527413 DOI: 10.1093/Schbul/Sbr033 |
0.376 |
|
2012 |
van Venrooij JA, Fluitman SB, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HG, Kahn RS, Gispen-de Wied CC. Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. 38: 272-9. PMID 20558533 DOI: 10.1093/Schbul/Sbq062 |
0.585 |
|
2012 |
Leeuw Md, Vink M, Kahn RS. Reward processing in unaffected siblings of schizophrenia patients: an fMRI study F1000research. 3. DOI: 10.7490/F1000Research.1092030.1 |
0.685 |
|
2012 |
Vorstman l, Anney R, Derks E, Gallagher L, Gill M, Jonge Md, Engeland Hv, Kahn R, Ophoff R. Poster #112 NO EVIDENCE THAT COMMON GENETIC RISK VARIANTS ARE SHARED BETWEEN SCHIZOPHRENIA AND AUTISM Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70945-3 |
0.36 |
|
2012 |
Vink M, Zandbelt BB, van Buuren M, Kahn RS. Poster #36 REDUCED PROACTIVE INHIBITORY CONTROL IN SCHIZOPHRENIA PATIENTS AND THEIR UNAFFECTED SIBLINGS Schizophrenia Research. 136: S293-S294. DOI: 10.1016/S0920-9964(12)70869-1 |
0.805 |
|
2012 |
Collin G, Van den Heuvel MP, De Reus MA, Boos HB, Calm W, Pol HEH, Kahn RS. Poster #48 FRONTOSTRIATAL DEPENDENCY IN GREY MATTER VOLUME IS REDUCED IN SCHIZOPHRENIA Schizophrenia Research. 136: S202-S203. DOI: 10.1016/S0920-9964(12)70620-5 |
0.379 |
|
2012 |
de Leeuw M, Vink M, Zandbelt BB, Kahn RS. Poster #22 HYPERACTIVATION IN WORKING MEMORY CIRCUITS IN SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 136: S99. DOI: 10.1016/S0920-9964(12)70338-9 |
0.797 |
|
2012 |
Collin G, Pol HEH, Haijma SV, Cahn W, Kahn RS, Heuvel MPVd. Poster #19 IMPAIRED CEREBELLAR FUNCTIONAL CONNECTIVITY IN SCHIZOPHRENIA PATIENTS AND THEIR HEALTHY SIBLINGS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70335-3 |
0.422 |
|
2011 |
Collin G, Hulshoff Pol HE, Haijma SV, Cahn W, Kahn RS, van den Heuvel MP. Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. Frontiers in Psychiatry. 2: 73. PMID 22203807 DOI: 10.3389/Fpsyt.2011.00073 |
0.43 |
|
2011 |
Kas MJ, Kahn RS, Collier DA, Waddington JL, Ekelund J, Porteous DJ, Schughart K, Hovatta I. Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man. Science Translational Medicine. 3: 102mr3. PMID 21957171 DOI: 10.1126/Scitranslmed.3002917 |
0.343 |
|
2011 |
Zandbelt BB, van Buuren M, Kahn RS, Vink M. Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biological Psychiatry. 70: 1151-8. PMID 21903198 DOI: 10.1016/J.Biopsych.2011.07.028 |
0.815 |
|
2011 |
van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry. 68: 871-80. PMID 21893656 DOI: 10.1001/Archgenpsychiatry.2011.88 |
0.372 |
|
2011 |
Daalman K, van Zandvoort M, Bootsman F, Boks M, Kahn R, Sommer I. Auditory verbal hallucinations and cognitive functioning in healthy individuals. Schizophrenia Research. 132: 203-7. PMID 21839618 DOI: 10.1016/J.Schres.2011.07.013 |
0.341 |
|
2011 |
Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 72: 955-61. PMID 21824456 DOI: 10.4088/Jcp.10M06529 |
0.377 |
|
2011 |
van Hell HH, Bossong MG, Jager G, Kahn RS, Ramsey NF. Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition. International Journal of Methods in Psychiatric Research. 20: 10-27. PMID 21574207 DOI: 10.1002/Mpr.327 |
0.539 |
|
2011 |
van Buuren M, Vink M, Rapcencu AE, Kahn RS. Exaggerated brain activation during emotion processing in unaffected siblings of patients with schizophrenia. Biological Psychiatry. 70: 81-7. PMID 21531384 DOI: 10.1016/J.Biopsych.2011.03.011 |
0.702 |
|
2011 |
van Veelen NM, Vink M, Ramsey NF, van Buuren M, Hoogendam JM, Kahn RS. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. Schizophrenia Research. 129: 156-62. PMID 21497488 DOI: 10.1016/J.Schres.2011.03.026 |
0.752 |
|
2011 |
Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, Termorshuizen F, Kahn RS, Boks MP, Ophoff RA. Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophrenia Research. 129: 128-32. PMID 21489755 DOI: 10.1016/J.Schres.2011.03.021 |
0.633 |
|
2011 |
van Hell HH, Bossong MG, Jager G, Kristo G, van Osch MJ, Zelaya F, Kahn RS, Ramsey NF. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1377-88. PMID 21489346 DOI: 10.1017/S1461145711000526 |
0.552 |
|
2011 |
Daalman K, Boks MP, Diederen KM, de Weijer AD, Blom JD, Kahn RS, Sommer IE. The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. The Journal of Clinical Psychiatry. 72: 320-5. PMID 21450152 DOI: 10.4088/Jcp.09M05797Yel |
0.333 |
|
2011 |
van Veelen NM, Vink M, Ramsey NF, Sommer IE, van Buuren M, Hoogendam JM, Kahn RS. Reduced language lateralization in first-episode medication-naive schizophrenia. Schizophrenia Research. 127: 195-201. PMID 21237617 DOI: 10.1016/J.Schres.2010.12.013 |
0.735 |
|
2011 |
Kahn RS, Linszen DH, Van Os J, Wiersma D, Bruggeman R, Cahn W, De Haan L, Krabbendam L, Myin-Germeys I. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: An analysis of patient-sibling and sibling-control pairs Archives of General Psychiatry. 68: 138-147. PMID 20921112 DOI: 10.1001/Archgenpsychiatry.2010.132 |
0.307 |
|
2011 |
Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, de Jonge M, Hennekam EA, Janson E, Staal WG, van der Zwaag B, Burbach JP, Kahn RS, Emanuel BS, van Engeland H, Ophoff RA. A double hit implicates DIAPH3 as an autism risk gene. Molecular Psychiatry. 16: 442-51. PMID 20308993 DOI: 10.1038/Mp.2010.26 |
0.636 |
|
2011 |
van Hell H, Jansma J, Bossong M, Kahn R, Ramsey N. P.6.c.005 Endocannabinoid involvement in brain reward processing in nicotine addiction European Neuropsychopharmacology. 21: S578. DOI: 10.1016/S0924-977X(11)70945-2 |
0.483 |
|
2011 |
van Hell H, Jansma J, Bossong M, Jager G, Noorman K, Kahn R, Ramsey N. P.1.e.031 Endocannabinoids may not be involved in response inhibition in humans European Neuropsychopharmacology. 21: S321. DOI: 10.1016/S0924-977X(11)70509-0 |
0.468 |
|
2011 |
Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.007 The effects of delta9-tetrahydrocannabinol (THC) on human brain function involved in emotional processing: a pharmacological fMRI study European Neuropsychopharmacology. 21: S307. DOI: 10.1016/S0924-977X(11)70485-0 |
0.499 |
|
2011 |
Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.006 Involvement of the endocannabinoid system in executive function: a pharmacological fMRI study with delta9-tetrahydrocannabinol (THC) European Neuropsychopharmacology. 21: S306-S307. DOI: 10.1016/S0924-977X(11)70484-9 |
0.485 |
|
2011 |
Van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: An fMRI study | Efectos crónicos del consumo de cannabis sobre el sistema de recompensa humano: un estudio de RMf Psiquiatria Biologica. 18: 45-54. DOI: 10.1016/J.Psiq.2011.08.003 |
0.676 |
|
2010 |
Diederen KM, De Weijer AD, Daalman K, Blom JD, Neggers SF, Kahn RS, Sommer IE. Decreased language lateralization is characteristic of psychosis, not auditory hallucinations. Brain : a Journal of Neurology. 133: 3734-44. PMID 21097491 DOI: 10.1093/Brain/Awq313 |
0.324 |
|
2010 |
Schnack HG, van Haren NE, Brouwer RM, van Baal GC, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Hulshoff Pol HE. Mapping reliability in multicenter MRI: voxel-based morphometry and cortical thickness. Human Brain Mapping. 31: 1967-82. PMID 21086550 DOI: 10.1002/Hbm.20991 |
0.459 |
|
2010 |
Van der Schot A, Kahn R, Ramsey N, Nolen W, Vink M. Trait and state dependent functional impairments in bipolar disorder. Psychiatry Research. 184: 135-42. PMID 21050725 DOI: 10.1016/J.Pscychresns.2010.07.009 |
0.729 |
|
2010 |
Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 855-65. PMID 20863671 DOI: 10.1016/J.Euroneuro.2010.08.008 |
0.383 |
|
2010 |
van der Schot AC, Vonk R, Brouwer RM, van Baal GC, Brans RG, van Haren NE, Schnack HG, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Genetic and environmental influences on focal brain density in bipolar disorder. Brain : a Journal of Neurology. 133: 3080-92. PMID 20837502 DOI: 10.1093/Brain/Awq236 |
0.345 |
|
2010 |
Vinkers CH, Mirza NR, Olivier B, Kahn RS. The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline. Expert Opinion On Investigational Drugs. 19: 1217-33. PMID 20812877 DOI: 10.1517/13543784.2010.513382 |
0.352 |
|
2010 |
van Veelen NM, Vink M, Ramsey NF, Kahn RS. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia. Schizophrenia Research. 123: 22-9. PMID 20724113 DOI: 10.1016/J.Schres.2010.07.004 |
0.765 |
|
2010 |
de Weijer AD, Mandl RC, Sommer IE, Vink M, Kahn RS, Neggers SF. Human fronto-tectal and fronto-striatal-tectal pathways activate differently during anti-saccades. Frontiers in Human Neuroscience. 4: 41. PMID 20631846 DOI: 10.3389/Fnhum.2010.00041 |
0.639 |
|
2010 |
Brans RG, Kahn RS, Schnack HG, van Baal GC, Posthuma D, van Haren NE, Lepage C, Lerch JP, Collins DL, Evans AC, Boomsma DI, Hulshoff Pol HE. Brain plasticity and intellectual ability are influenced by shared genes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 5519-24. PMID 20410105 DOI: 10.1523/Jneurosci.5841-09.2010 |
0.32 |
|
2010 |
Diederen KM, Neggers SF, Daalman K, Blom JD, Goekoop R, Kahn RS, Sommer IE. Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. The American Journal of Psychiatry. 167: 427-35. PMID 20123912 DOI: 10.1176/Appi.Ajp.2009.09040456 |
0.35 |
|
2010 |
van Buuren M, Gladwin TE, Zandbelt BB, Kahn RS, Vink M. Reduced functional coupling in the default-mode network during self-referential processing. Human Brain Mapping. 31: 1117-27. PMID 20108218 DOI: 10.1002/Hbm.20920 |
0.775 |
|
2010 |
van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: an fMRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 153-63. PMID 20061126 DOI: 10.1016/J.Euroneuro.2009.11.010 |
0.699 |
|
2010 |
Réthelyi JM, Bakker SC, Polgár P, Czobor P, Strengman E, Pásztor PI, Kahn RS, Bitter I. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 792-801. PMID 19937977 DOI: 10.1002/Ajmg.B.31049 |
0.369 |
|
2010 |
Koning JP, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophrenia Bulletin. 36: 723-31. PMID 18990712 DOI: 10.1093/Schbul/Sbn146 |
0.39 |
|
2010 |
Vink M, Zandbelt BB, Buuren Mv, Kahn RS. Stop-signal response inhibition deficits in schizophrenia patients and their unaffected siblings F1000research. 1. DOI: 10.7490/F1000Research.694.1 |
0.804 |
|
2010 |
Jager G, van Hell H, Bossong M, Kristo G, Kahn R, Ramsey N. P.1.e.009 Delta9-THC induces non-specific psychotropic effects reflected in resting-state brain function: a pharmaco-imaging study European Neuropsychopharmacology. 20: S293. DOI: 10.1016/S0924-977X(10)70388-6 |
0.502 |
|
2010 |
Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.1.e.005 Delta9-tetrahydrocannabinol (THC) impairs working memory system capacity: a pharmacological MRI study European Neuropsychopharmacology. 20: S290-S291. DOI: 10.1016/S0924-977X(10)70384-9 |
0.481 |
|
2010 |
van Hell H, Jager G, Brouwer A, Bossong M, Kahn R, Ramsey N. P.3.024 Addiction proneness: contribution of the endocannabinoid system and reward processing European Neuropsychopharmacology. 20: S82. DOI: 10.1016/S0924-977X(10)70096-1 |
0.472 |
|
2010 |
Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.3.003 Involvement of the endocannabinoid system in working memory: a pharmacological MRI study with delta9-THC European Neuropsychopharmacology. 20: S64. DOI: 10.1016/S0924-977X(10)70075-4 |
0.479 |
|
2010 |
Widschwendter CG, Vink M, Zandbelt BB, Kahn RS. EVIDENCE FOR DECREASED FRONTO-STRIATAL FUNCTIONING IN SCHIZOPHRENIA DURING WORKING MEMORY Schizophrenia Research. 117: 476. DOI: 10.1016/J.Schres.2010.02.897 |
0.795 |
|
2010 |
Hoogendam JM, van Veelen NM, Vink M, Kahn RS. DECREASED LANGUAGE LATERALIZATION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 475-476. DOI: 10.1016/J.Schres.2010.02.896 |
0.659 |
|
2010 |
van Buuren M, Vink M, Kahn RS. ABERRANT COUPLING WITHIN THE DEFAULT-MODE NETWORK DURING SELF-REFERENTIAL PROCESSING IN HEALTHY SIBLINGS OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 117: 474. DOI: 10.1016/J.Schres.2010.02.893 |
0.665 |
|
2010 |
Schnack HG, Haren NEMv, Brouwer RM, Baal GCMv, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Pol HEH. Mapping Reliability Of Multicenter Mri: Cortical Thickness And Voxel-Based Morphometry Schizophrenia Research. 117: 461-461. DOI: 10.1016/J.Schres.2010.02.861 |
0.543 |
|
2010 |
Terwisscha van Schel AF, Bakker SC, van Haren NE, Pol HEH, Cahn W, Buizer-Voskamp JE, Gladwin TE, Vorstman JA, Ophoff RA, Kahn RS. ASSOCIATION STUDY OF CNVS WITH BRAIN VOLUME AND BRAIN VOLUME CHANGE OVER 5 YEARS IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS Schizophrenia Research. 117: 454. DOI: 10.1016/J.Schres.2010.02.845 |
0.385 |
|
2010 |
van Veelen NM, Vink M, Ramsey NF, Kahn RS. LEFT PRE-FRONTAL LOBE DYSFUNCTION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 359. DOI: 10.1016/J.Schres.2010.02.631 |
0.733 |
|
2010 |
Buizer-Voskamp JE, Laan W, Boks MPM, Staal WG, Hennekam EAM, Aukes MF, Kahn RS, Ophoff RA. Parental Age And The Risk Of Psychiatric Disorders Schizophrenia Research. 117: 194-194. DOI: 10.1016/J.Schres.2010.02.255 |
0.6 |
|
2010 |
van Haren NE, Rijsdijk F, Schnack H, Picchioni M, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Boomsma D, Hulshoff Pol HE, Murray RM, Kahn RS. THE STAR CONSORTIUM: DO GENES OR ENVIRONMENT EXPLAIN THE ASSOCIATION BETWEEN SCHIZOPHRENIA AND A SMALLER BRAIN? Schizophrenia Research. 117: 171-172. DOI: 10.1016/J.Schres.2010.02.200 |
0.364 |
|
2009 |
Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophrenia Research. 115: 104-14. PMID 19822407 DOI: 10.1016/J.Schres.2009.09.022 |
0.342 |
|
2009 |
Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophrenia Research. 115: 97-103. PMID 19819114 DOI: 10.1016/J.Schres.2009.09.019 |
0.315 |
|
2009 |
Kemner C, Foxe JJ, Tankink JE, Kahn RS, Lamme VA. Abnormal timing of visual feedback processing in young adults with schizophrenia. Neuropsychologia. 47: 3105-10. PMID 19631672 DOI: 10.1016/J.Neuropsychologia.2009.07.009 |
0.35 |
|
2009 |
Grootens KP, van Veelen NM, Peuskens J, Sabbe BG, Thys E, Buitelaar JK, Verkes RJ, Kahn RS. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophrenia Bulletin. 37: 352-61. PMID 19542525 DOI: 10.1093/Schbul/Sbp037 |
0.386 |
|
2009 |
van 't Wout M, van Rijn S, Jellema T, Kahn RS, Aleman A. Deficits in implicit attention to social signals in schizophrenia and high risk groups: behavioural evidence from a new illusion. Plos One. 4: e5581. PMID 19440352 DOI: 10.1371/Journal.Pone.0005581 |
0.371 |
|
2009 |
Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, ... ... Kahn RS, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). The American Journal of Psychiatry. 166: 675-82. PMID 19369319 DOI: 10.1176/Appi.Ajp.2008.08060806 |
0.355 |
|
2009 |
Peper JS, Schnack HG, Brouwer RM, Van Baal GC, Pjetri E, Székely E, van Leeuwen M, van den Berg SM, Collins DL, Evans AC, Boomsma DI, Kahn RS, Hulshoff Pol HE. Heritability of regional and global brain structure at the onset of puberty: a magnetic resonance imaging study in 9-year-old twin pairs. Human Brain Mapping. 30: 2184-96. PMID 19294640 DOI: 10.1002/Hbm.20660 |
0.321 |
|
2009 |
van der Schot AC, Vonk R, Brans RG, van Haren NE, Koolschijn PC, Nuboer V, Schnack HG, van Baal GC, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Archives of General Psychiatry. 66: 142-51. PMID 19188536 DOI: 10.1001/Archgenpsychiatry.2008.541 |
0.329 |
|
2009 |
van Buuren M, Gladwin TE, Zandbelt BB, van den Heuvel M, Ramsey NF, Kahn RS, Vink M. Cardiorespiratory effects on default-mode network activity as measured with fMRI. Human Brain Mapping. 30: 3031-42. PMID 19180557 DOI: 10.1002/Hbm.20729 |
0.779 |
|
2009 |
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 823-32. PMID 19154656 DOI: 10.1017/S1461145708009814 |
0.585 |
|
2009 |
Grootens KP, Vermeeren L, Verkes RJ, Buitelaar JK, Sabbe BG, van Veelen N, Kahn RS, Hulstijn W. Psychomotor planning is deficient in recent-onset schizophrenia. Schizophrenia Research. 107: 294-302. PMID 19008079 DOI: 10.1016/J.Schres.2008.09.032 |
0.394 |
|
2009 |
Peper JS, Brouwer RM, Schnack HG, Baal GCMv, Leeuwen Mv, Berg SMvd, Waal HDd, Boomsma DI, Kahn RS, Pol HEH. Sex steroids and brain structure in pubertal boys and girls Psychoneuroendocrinology. 34: 332-342. PMID 18980810 DOI: 10.1016/J.Psyneuen.2008.09.012 |
0.316 |
|
2009 |
Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, Rappaport EF, Beemer FA, Emanuel BS, Kahn RS, van Engeland H, Kemner C. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 739-46. PMID 18769474 DOI: 10.1038/Npp.2008.132 |
0.338 |
|
2009 |
Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JM, Ramsey NF, Lammertsma AA, Kahn RS. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 759-66. PMID 18754005 DOI: 10.1016/J.Neuroimage.2008.04.231 |
0.502 |
|
2009 |
Vorstman JA, Chow EW, Ophoff RA, van Engeland H, Beemer FA, Kahn RS, Sinke RJ, Bassett AS. Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 430-3. PMID 18646052 DOI: 10.1002/Ajmg.B.30827 |
0.381 |
|
2009 |
Vink M, Zandbelt B, van Buuren M, Kahn R, Gladwin T. Anticipation and execution of response inhibition Neuroimage. 47: S190. DOI: 10.1016/S1053-8119(09)72124-X |
0.759 |
|
2009 |
van Buuren M, Gladwin T, Zandbelt B, Kahn R, Vink M. Activity and connectivity within the default-mode network during self-referential processing after removal of cardiorespiratory confounds Neuroimage. 47: S133. DOI: 10.1016/S1053-8119(09)71304-7 |
0.76 |
|
2009 |
Zandbelt B, Hoogendam J, Van Buuren M, Sack A, Kahn R, Vink M. Repetitive Transcranial Magnetic Stimulation Alters Resting-State Functional Connectivity Neuroimage. 47: S74. DOI: 10.1016/S1053-8119(09)70478-1 |
0.76 |
|
2009 |
Bossong M, Van Hell H, Jager G, Brouwer A, Kahn R, Ramsey N. P.1.e.015 Involvement of the endocannabinoid system in associative memory: a pharmacological MRI study European Neuropsychopharmacology. 19: S308-S309. DOI: 10.1016/S0924-977X(09)70459-6 |
0.481 |
|
2009 |
van Hell H, Bossong M, Jager G, Saliasi E, Kahn R, Ramsey N. P.1.e.014 The acute effects of delta-9-tetrahydro-cannabinol (THC) on brain activity during working memory European Neuropsychopharmacology. 19: S308. DOI: 10.1016/S0924-977X(09)70458-4 |
0.495 |
|
2009 |
Buizer-Voskamp J, Muntjewerff J, Vorstman J, Franke L, Hochstenbach P, Ophoff R, Kahn R. P.1.04 Schizophrenia and cytogenetic aberrations: in search of susceptibility genes and pathways European Neuropsychopharmacology. 19: S5-S6. DOI: 10.1016/S0924-977X(09)70007-0 |
0.348 |
|
2008 |
Mandl RC, Schnack HG, Zwiers MP, van der Schaaf A, Kahn RS, Hulshoff Pol HE. Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. Plos One. 3: e3631. PMID 18982065 DOI: 10.1371/Journal.Pone.0003631 |
0.306 |
|
2008 |
Brans RG, van Haren NE, van Baal GC, Staal WG, Schnack HG, Kahn RS, Hulshoff Pol HE. Longitudinal MRI study in schizophrenia patients and their healthy siblings. The British Journal of Psychiatry : the Journal of Mental Science. 193: 422-3. PMID 18978326 DOI: 10.1192/Bjp.Bp.107.041467 |
0.697 |
|
2008 |
Zandbelt BB, Gladwin TE, Raemaekers M, van Buuren M, Neggers SF, Kahn RS, Ramsey NF, Vink M. Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage. 42: 196-206. PMID 18538585 DOI: 10.1016/J.Neuroimage.2008.04.183 |
0.77 |
|
2008 |
Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 371: 1085-97. PMID 18374841 DOI: 10.1016/S0140-6736(08)60486-9 |
0.35 |
|
2008 |
van Rijn S, Aleman A, Swaab H, Vink M, Sommer I, Kahn RS. Effects of an extra X chromosome on language lateralization: an fMRI study with Klinefelter men (47,XXY). Schizophrenia Research. 101: 17-25. PMID 18372164 DOI: 10.1016/J.Schres.2008.02.001 |
0.642 |
|
2008 |
Rietkerk T, Boks MPM, Sommer IE, Liddle PF, Ophoff RA, Kahn RS. The genetics of symptom dimensions of schizophrenia: Review and meta-analysis Schizophrenia Research. 102: 197-205. PMID 18328672 DOI: 10.1016/J.Schres.2008.01.023 |
0.353 |
|
2008 |
Baas D, Aleman A, Vink M, Ramsey NF, de Haan EH, Kahn RS. Evidence of altered cortical and amygdala activation during social decision-making in schizophrenia. Neuroimage. 40: 719-27. PMID 18261933 DOI: 10.1016/J.Neuroimage.2007.12.039 |
0.74 |
|
2008 |
Boks MPM, Hoogendoorn M, Jungerius BJ, Bakker SC, Sommer IE, Sinke RJ, Ophoff RA, Kahn RS. Do mood symptoms subdivide the schizophrenia phenotype? Association of the GMP6A gene with a depression subgroup American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics. 147: 707-711. PMID 18163405 DOI: 10.1002/Ajmg.B.30667 |
0.408 |
|
2008 |
van Raalten TR, Ramsey NF, Jansma JM, Jager G, Kahn RS. Automatization and working memory capacity in schizophrenia. Schizophrenia Research. 100: 161-71. PMID 18155446 DOI: 10.1016/J.Schres.2007.10.035 |
0.571 |
|
2008 |
Sommer IE, Cohen-Kettenis PT, van Raalten T, Vd Veer AJ, Ramsey LE, Gooren LJ, Kahn RS, Ramsey NF. Effects of cross-sex hormones on cerebral activation during language and mental rotation: An fMRI study in transsexuals. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 215-21. PMID 17997284 DOI: 10.1016/J.Euroneuro.2007.10.002 |
0.492 |
|
2008 |
Baas D, van't Wout M, Aleman A, Kahn RS. Social judgement in clinically stable patients with schizophrenia and healthy relatives: behavioural evidence of social brain dysfunction. Psychological Medicine. 38: 747-54. PMID 17988413 DOI: 10.1017/S0033291707001729 |
0.394 |
|
2008 |
Hoogendoorn MLC, Vorstman JAS, Jalali GR, Selten JP, Sinke RJ, Emanuel BS, Kahn RS. Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia Schizophrenia Research. 98: 84-88. PMID 17964762 DOI: 10.1016/J.Schres.2007.09.025 |
0.363 |
|
2008 |
Scholten MR, Aleman A, Kahn RS. The processing of emotional prosody and semantics in schizophrenia: relationship to gender and IQ. Psychological Medicine. 38: 887-98. PMID 17949518 DOI: 10.1017/S0033291707001742 |
0.307 |
|
2008 |
Jungerius BJ, Bakker SC, Monsuur AJ, Sinke RJ, Kahn RS, Wijmenga C. Is MYO9B the missing link between schizophrenia and celiac disease? American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 351-5. PMID 17948900 DOI: 10.1002/Ajmg.B.30605 |
0.375 |
|
2008 |
Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, Faas BH, Knoers NV, Cahn W, Kahn RS, Edelmann L, Davis KL, Silverman JM, Brunner HG, van Kessel AG, Wijmenga C, et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Molecular Psychiatry. 13: 261-6. PMID 17646849 DOI: 10.1038/Sj.Mp.4002049 |
0.323 |
|
2008 |
Jager G, de Win MM, van der Tweel I, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 247-58. PMID 17460617 DOI: 10.1038/Sj.Npp.1301415 |
0.643 |
|
2008 |
van Veelen N, Vink M, Ramsey N, Kahn R. P.3.17 Do patients benefit from practice? An fMRI study in first episode schizophrenia European Neuropsychopharmacology. 18: s76-s77. DOI: 10.1016/S0924-977X(08)70088-9 |
0.741 |
|
2008 |
Koning J, van Harten P, Aleman A, Kahn RS. SPONTANEOUS DYSKINESIA AND PARKINSONISMIN SCHIZOPHRENIA AND THEIR SIBLINGS. A SYSTEMATIC REVIEWAND META-ANALYSIS Schizophrenia Research. 102: 153. DOI: 10.1016/S0920-9964(08)70466-3 |
0.351 |
|
2008 |
Schnack H, Haren Nv, Picchioni M, Weisbrod M, Sauer H, Cannon T, Huttunen M, Murray R, Kahn R, Pol HH. A Multicenter Mri Schizophrenia Study: Reliability Of Voxel-Based Morphometry Schizophrenia Research. 102: 75. DOI: 10.1016/S0920-9964(08)70231-7 |
0.537 |
|
2008 |
Bakker S, van Haren N, Hoogendoorn M, Koolschijn C, Pol HH, Sinke R, Ophoff R, Kahn R. ASSOCIATION OF FIBROBLAST GROWTH FACTOR 2 (FGF2) WITH HIPPOCAMPAL VOLUME IN DUTCH SCHIZOPHRENIA PATIENTS Schizophrenia Research. 102: 16. DOI: 10.1016/S0920-9964(08)70053-7 |
0.408 |
|
2007 |
Van't Wout M, van Dijke A, Aleman A, Kessels RP, Pijpers W, Kahn RS. Fearful faces in schizophrenia: the relationship between patient characteristics and facial affect recognition. The Journal of Nervous and Mental Disease. 195: 758-64. PMID 17984776 DOI: 10.1097/Nmd.0B013E318142Cc31 |
0.354 |
|
2007 |
Jungerius BJ, Hoogendoorn ML, Bakker SC, Van't Slot R, Bardoel AF, Ophoff RA, Wijmenga C, Kahn RS, Sinke RJ. An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia. Molecular Psychiatry. 13: 1060-8. PMID 17893707 DOI: 10.1038/Sj.Mp.4002080 |
0.334 |
|
2007 |
Hoekert M, Kahn RS, Pijnenborg M, Aleman A. Impaired recognition and expression of emotional prosody in schizophrenia: review and meta-analysis. Schizophrenia Research. 96: 135-45. PMID 17766089 DOI: 10.1016/J.Schres.2007.07.023 |
0.333 |
|
2007 |
Raemaekers M, Vink M, Zandbelt B, van Wezel RJ, Kahn RS, Ramsey NF. Test-retest reliability of fMRI activation during prosaccades and antisaccades. Neuroimage. 36: 532-42. PMID 17499525 DOI: 10.1016/J.Neuroimage.2007.03.061 |
0.773 |
|
2007 |
Jager G, de Win MM, Vervaeke HK, Schilt T, Kahn RS, van den Brink W, van Ree JM, Ramsey NF. Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study. Psychopharmacology. 193: 403-14. PMID 17476480 DOI: 10.1007/S00213-007-0792-1 |
0.647 |
|
2007 |
Peper JS, Brouwer RM, Boomsma DI, Kahn RS, Hulshoff Pol HE. Genetic influences on human brain structure: a review of brain imaging studies in twins. Human Brain Mapping. 28: 464-73. PMID 17415783 DOI: 10.1002/Hbm.20398 |
0.321 |
|
2007 |
Bakker SC, Hoogendoorn ML, Hendriks J, Verzijlbergen K, Caron S, Verduijn W, Selten JP, Pearson PL, Kahn RS, Sinke RJ. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes, Brain, and Behavior. 6: 113-9. PMID 17410640 DOI: 10.1111/J.1601-183X.2006.00234.X |
0.38 |
|
2007 |
Boos HB, Aleman A, Cahn W, Hulshoff Pol H, Kahn RS. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Archives of General Psychiatry. 64: 297-304. PMID 17339518 DOI: 10.1001/Archpsyc.64.3.297 |
0.402 |
|
2007 |
van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Mandl RC, Collins DL, Evans AC, Kahn RS. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2057-66. PMID 17327887 DOI: 10.1038/Sj.Npp.1301347 |
0.399 |
|
2007 |
van 't Wout M, Aleman A, Kessels RP, Cahn W, de Haan EH, Kahn RS. Exploring the nature of facial affect processing deficits in schizophrenia. Psychiatry Research. 150: 227-35. PMID 17313979 DOI: 10.1016/J.Psychres.2006.03.010 |
0.365 |
|
2007 |
van 't Wout M, Aleman A, Bermond B, Kahn RS. No words for feelings: alexithymia in schizophrenia patients and first-degree relatives. Comprehensive Psychiatry. 48: 27-33. PMID 17145278 DOI: 10.1016/J.Comppsych.2006.07.003 |
0.396 |
|
2007 |
Jager G, Van Hell HH, De Win MM, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 289-97. PMID 17137758 DOI: 10.1016/J.Euroneuro.2006.10.003 |
0.647 |
|
2007 |
van der Wee NJ, Ramsey NF, van Megen HJ, Denys D, Westenberg HG, Kahn RS. Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 16-23. PMID 16797166 DOI: 10.1016/J.Euroneuro.2006.04.012 |
0.753 |
|
2007 |
van Hell H, Jager G, Vink M, Ossewaarde L, Kahn R, Ramsey N. P.6.d.005 Differential effects of cannabis and nicotine on the human reward system European Neuropsychopharmacology. 17: S554. DOI: 10.1016/S0924-977X(07)70860-X |
0.664 |
|
2006 |
Hulshoff Pol HE, Schnack HG, Posthuma D, Mandl RC, Baaré WF, van Oel C, van Haren NE, Collins DL, Evans AC, Amunts K, Bürgel U, Zilles K, de Geus E, Boomsma DI, Kahn RS. Genetic contributions to human brain morphology and intelligence. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 10235-42. PMID 17021179 DOI: 10.1523/Jneurosci.1312-06.2006 |
0.309 |
|
2006 |
Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS, McEvoy JP, Perkins DO, Rothschild AJ, Sharma T, Tohen MF, Woolson S, Zipursky RB. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophrenia Research. 86: 234-43. PMID 16887334 DOI: 10.1016/J.Schres.2006.06.021 |
0.359 |
|
2006 |
Raemaekers M, Vink M, van den Heuvel MP, Kahn RS, Ramsey NF. Effects of aging on BOLD fMRI during prosaccades and antisaccades. Journal of Cognitive Neuroscience. 18: 594-603. PMID 16768362 DOI: 10.1162/Jocn.2006.18.4.594 |
0.713 |
|
2006 |
van der Wee NJ, Hardeman HH, Ramsey NF, Raemaekers M, Van Megen HJ, Denys DA, Westenberg HG, Kahn RS. Saccadic abnormalities in psychotropic-naive obsessive-compulsive disorder without co-morbidity. Psychological Medicine. 36: 1321-6. PMID 16734943 DOI: 10.1017/S0033291706007926 |
0.74 |
|
2006 |
Scholten MR, van Honk J, Aleman A, Kahn RS. Behavioral inhibition system (BIS), behavioral activation system (BAS) and schizophrenia: relationship with psychopathology and physiology. Journal of Psychiatric Research. 40: 638-45. PMID 16643947 DOI: 10.1016/J.Jpsychires.2006.03.005 |
0.378 |
|
2006 |
Vink M, Ramsey NF, Raemaekers M, Kahn RS. Striatal dysfunction in schizophrenia and unaffected relatives. Biological Psychiatry. 60: 32-9. PMID 16603134 DOI: 10.1016/J.Biopsych.2005.11.026 |
0.763 |
|
2006 |
Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, Green AI, Glick IB, Kahn RS, Sharma T, Tohen M, McEvoy JP, Weiden PJ, Lieberman JA. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophrenia Research. 83: 53-63. PMID 16529910 DOI: 10.1016/J.Schres.2005.10.016 |
0.31 |
|
2006 |
Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF. Long-term effects of frequent cannabis use on working memory and attention: an fMRI study. Psychopharmacology. 185: 358-68. PMID 16521034 DOI: 10.1007/s00213-005-0298-7 |
0.615 |
|
2006 |
Hulshoff Pol HE, Schnack HG, Mandl RC, Brans RG, van Haren NE, Baaré WF, van Oel CJ, Collins DL, Evans AC, Kahn RS. Gray and white matter density changes in monozygotic and same-sex dizygotic twins discordant for schizophrenia using voxel-based morphometry. Neuroimage. 31: 482-8. PMID 16497519 DOI: 10.1016/J.Neuroimage.2005.12.056 |
0.396 |
|
2006 |
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention. Journal of Psychopharmacology (Oxford, England). 20: 789-98. PMID 16478755 DOI: 10.1177/0269881106061712 |
0.614 |
|
2006 |
Sommer IE, Oranje B, Ramsey NF, Klerk FA, Mandl RC, Westenberg HG, Kahn RS. The influence of amphetamine on language activation: an fMRI study. Psychopharmacology. 183: 387-93. PMID 16284750 DOI: 10.1007/S00213-005-0176-3 |
0.652 |
|
2006 |
Raemaekers M, Ramsey NF, Vink M, van den Heuvel MP, Kahn RS. Brain activation during antisaccades in unaffected relatives of schizophrenic patients. Biological Psychiatry. 59: 530-5. PMID 16165103 DOI: 10.1016/J.Biopsych.2005.07.030 |
0.768 |
|
2006 |
Rijsdijk FV, van Haren NE, Picchioni MM, McDonald C, Toulopoulou T, Hulshoff Pol HE, Kahn RS, Murray R, Sham PC. Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychological Medicine. 35: 1399-409. PMID 16164764 DOI: 10.1017/S0033291705005167 |
0.392 |
|
2006 |
Jager G, de Win M, van der Tweel I, Kahn R, van Ree J, van den Brink W, Ramsey N. Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy users European Neuropsychopharmacology. 16: S80-S81. DOI: 10.1016/S0924-977X(06)80095-7 |
0.469 |
|
2006 |
van Rijn S, Swaab H, Aleman A, Jellema T, Kahn R. Abnormal social cognitive processing in 47, XXY men: implications for the study of schizophrenia European Neuropsychopharmacology. 16: S54-S55. DOI: 10.1016/S0924-977X(06)80066-0 |
0.339 |
|
2006 |
Baas D, Aleman A, Ramsey N, De Haan E, Kahn R. P.1.e.027 Imaging neural interactions during social information processing in schizophrenia European Neuropsychopharmacology. 16: S274. DOI: 10.1016/S0924-977X(06)70262-0 |
0.532 |
|
2006 |
Jager G, De Win M, Kahn R, Van Ree J, Van den Brink W, Ramsey N. S.07.06 Specific effects of ecstasy on memory: a new approach to investigate neurotoxic effects in poly-substance ecstasy users European Neuropsychopharmacology. 16: S176-S177. DOI: 10.1016/S0924-977X(06)70049-9 |
0.4 |
|
2005 |
Aleman A, Kahn RS. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Progress in Neurobiology. 77: 283-98. PMID 16352388 DOI: 10.1016/J.Pneurobio.2005.11.005 |
0.351 |
|
2005 |
Scholten MR, Aleman A, Montagne B, Kahn RS. Schizophrenia and processing of facial emotions: sex matters. Schizophrenia Research. 78: 61-7. PMID 16084696 DOI: 10.1016/J.Schres.2005.06.019 |
0.342 |
|
2005 |
Fleischhacker WW, Keet IPM, Kahn RS, Hummer M, Peuskens J, Hranov LG, Libiger J, Dollfus S, Gaebel W, Davidson M, Galderisi S, Boter H, Rybakowski J, Gheorghe M, Ibor JJL, et al. The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial Schizophrenia Research. 78: 147-156. PMID 16055308 DOI: 10.1016/J.Schres.2005.06.004 |
0.384 |
|
2005 |
Vink M, Ramsey NF, Raemaekers M, Kahn RS. Negative priming in schizophrenia revisited. Schizophrenia Research. 79: 211-6. PMID 15978779 DOI: 10.1016/J.Schres.2005.05.004 |
0.743 |
|
2005 |
Raemaekers M, Vink M, van den Heuvel MP, Kahn RS, Ramsey NF. Brain activation related to retrosaccades in saccade experiments. Neuroreport. 16: 1043-7. PMID 15973145 DOI: 10.1097/00001756-200507130-00003 |
0.708 |
|
2005 |
de Krom M, Bakker SC, Hendriks J, van Elburg A, Hoogendoorn M, Verduijn W, Sinke R, Kahn R, Adan RA. Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients. Psychiatric Genetics. 15: 81. PMID 15900221 DOI: 10.1097/00041444-200506000-00003 |
0.368 |
|
2005 |
Vink M, Kahn RS, Raemaekers M, van den Heuvel M, Boersma M, Ramsey NF. Function of striatum beyond inhibition and execution of motor responses. Human Brain Mapping. 25: 336-44. PMID 15852388 DOI: 10.1002/Hbm.20111 |
0.695 |
|
2005 |
Vink M, Kahn RS, Raemaekers M, Ramsey NF. Perceptual bias following visual target selection. Neuroimage. 25: 1168-74. PMID 15850734 DOI: 10.1016/J.Neuroimage.2004.12.042 |
0.701 |
|
2005 |
Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry. 62: 361-70. PMID 15809403 DOI: 10.1001/Archpsyc.62.4.361 |
0.391 |
|
2005 |
van der Heijden FM, Tuinier S, Arts NJ, Hoogendoorn ML, Kahn RS, Verhoeven WM. Catatonia: disappeared or under-diagnosed? Psychopathology. 38: 3-8. PMID 15714008 DOI: 10.1159/000083964 |
0.601 |
|
2005 |
Hoogendoorn ML, Bakker SC, Schnack HG, Selten JP, Otten HG, Verduijn W, van der Heijden FM, Pearson PL, Kahn RS, Sinke RJ. No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 134: 6-9. PMID 15635698 DOI: 10.1002/Ajmg.B.30147 |
0.342 |
|
2005 |
Sitskoorn MM, Ebisch SJ, Appels M, Nuyen J, Kahn RS. Memory profiles in parents of patients with schizophrenia. Psychiatry Research. 128: 27-37. PMID 15450912 DOI: 10.1016/J.Psychres.2004.05.011 |
0.393 |
|
2005 |
Heijden FMMAvd, Fekkes D, Tuinier S, Sijben AES, Kahn RS, Verhoeven WMA. Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics? Journal of Neural Transmission. 112: 577-585. PMID 15372327 DOI: 10.1007/S00702-004-0200-5 |
0.332 |
|
2004 |
van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ, Kahn RS, Westenberg HM. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. The American Journal of Psychiatry. 161: 2201-6. PMID 15569890 DOI: 10.1176/Appi.Ajp.161.12.2201 |
0.569 |
|
2004 |
Sitskoorn MM, Aleman A, Ebisch SJ, Appels MC, Kahn RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophrenia Research. 71: 285-95. PMID 15474899 DOI: 10.1016/J.Schres.2004.03.007 |
0.389 |
|
2004 |
Haren NEMV, Picchioni MM, Mcdonald C, Marshall N, Davis N, Ribchester T, Pol HEH, Sharma T, Sham P, Kahn RS, Murray RM. A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia Biological Psychiatry. 56: 454-461. PMID 15364044 DOI: 10.1016/J.Biopsych.2004.06.033 |
0.408 |
|
2004 |
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating. Journal of Psychopharmacology (Oxford, England). 18: 388-94. PMID 15358983 DOI: 10.1177/026988110401800310 |
0.593 |
|
2004 |
Bakker SC, Hoogendoorn ML, Selten JP, Verduijn W, Pearson PL, Sinke RJ, Kahn RS. Neuregulin 1: genetic support for schizophrenia subtypes. Molecular Psychiatry. 9: 1061-3. PMID 15303101 DOI: 10.1038/Sj.Mp.4001564 |
0.409 |
|
2004 |
van der Heijden FM, Tuinier S, Kahn RS, Verhoeven WM. Nonschizophrenic psychotic disorders: the case of cycloid psychoses. Psychopathology. 37: 161-7. PMID 15237245 DOI: 10.1159/000079419 |
0.545 |
|
2004 |
Perkins DO, Lieberman JA, Gu H, Tohen M, McEvoy J, Green AI, Zipursky RB, Strakowski SM, Sharma T, Kahn RS, Gur R, Tollefson G. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders British Journal of Psychiatry. 185: 18-24. PMID 15231551 DOI: 10.1192/Bjp.185.1.18 |
0.367 |
|
2004 |
Schnack HG, van Haren NE, Hulshoff Pol HE, Picchioni M, Weisbrod M, Sauer H, Cannon T, Huttunen M, Murray R, Kahn RS. Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Human Brain Mapping. 22: 312-20. PMID 15202109 DOI: 10.1002/Hbm.20040 |
0.473 |
|
2004 |
van 't Wout M, Aleman A, Kessels RP, Larøi F, Kahn RS. Emotional processing in a non-clinical psychosis-prone sample. Schizophrenia Research. 68: 271-81. PMID 15099609 DOI: 10.1016/J.Schres.2003.09.006 |
0.312 |
|
2004 |
Jansma JM, Ramsey NF, van der Wee NJ, Kahn RS. Working memory capacity in schizophrenia: a parametric fMRI study. Schizophrenia Research. 68: 159-71. PMID 15099600 DOI: 10.1016/S0920-9964(03)00127-0 |
0.723 |
|
2004 |
Hulshoff Pol HE, Schnack HG, Mandl RC, Cahn W, Collins DL, Evans AC, Kahn RS. Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage. 21: 27-35. PMID 14741639 DOI: 10.1016/J.Neuroimage.2003.09.026 |
0.403 |
|
2004 |
Ramsey NF, Jansma JM, Jager G, Van Raalten T, Kahn RS. Neurophysiological factors in human information processing capacity. Brain : a Journal of Neurology. 127: 517-25. PMID 14691061 DOI: 10.1093/Brain/Awh060 |
0.515 |
|
2004 |
Aleman A, de Haan EHF, Kahn RS. Underconstrained perception or underconstrained theory? Behavioral and Brain Sciences. 27: 787-788. DOI: 10.1017/S0140525X04220180 |
0.363 |
|
2004 |
Kahn R, van der Schot A, Ramsey N, Vink M, Majdandzic J, Nolen W. S.06.04 Visual processing of (un)masked facial affectin euthymic bipolar patients European Neuropsychopharmacology. 14: S122-S123. DOI: 10.1016/S0924-977X(04)80020-8 |
0.684 |
|
2003 |
van der Wee NJ, Ramsey NF, Jansma JM, Denys DA, van Megen HJ, Westenberg HM, Kahn RS. Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage. 20: 2271-80. PMID 14683728 DOI: 10.1016/J.Neuroimage.2003.05.001 |
0.696 |
|
2003 |
Aleman A, Böcker KB, Hijman R, de Haan EH, Kahn RS. Cognitive basis of hallucinations in schizophrenia: role of top-down information processing. Schizophrenia Research. 64: 175-85. PMID 14613682 DOI: 10.1016/S0920-9964(03)00060-4 |
0.355 |
|
2003 |
Kromkamp M, Uylings HB, Smidt MP, Hellemons AJ, Burbach JP, Kahn RS. Decreased thalamic expression of the homeobox gene DLX1 in psychosis. Archives of General Psychiatry. 60: 869-74. PMID 12963668 DOI: 10.1001/Archpsyc.60.9.869 |
0.386 |
|
2003 |
Appels MC, Sitskoorn MM, Westers P, Lems E, Kahn RS. Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients. Schizophrenia Research. 63: 285-93. PMID 12957707 DOI: 10.1016/S0920-9964(02)00342-0 |
0.352 |
|
2003 |
Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. The American Journal of Psychiatry. 160: 1396-404. PMID 12900300 DOI: 10.1176/Appi.Ajp.160.8.1396 |
0.358 |
|
2003 |
Selten JP, Cantor-Graae E, Nahon D, Levav I, Aleman A, Kahn RS. No relationship between risk of schizophrenia and prenatal exposure to stress during the Six-Day War or Yom Kippur War in Israel. Schizophrenia Research. 63: 131-5. PMID 12892867 DOI: 10.1016/S0920-9964(02)00375-4 |
0.327 |
|
2003 |
Terpstra J, Gispen-De Wied CC, Broekhoven MH, Frankhuijzen AC, Kahn RS, van Ree JM, Wiegant VM. Attenuated stress responsiveness in an animal model for neurodevelopmental psychopathological disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 13: 249-56. PMID 12888184 DOI: 10.1016/S0924-977X(03)00010-5 |
0.545 |
|
2003 |
Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry. 60: 565-71. PMID 12796219 DOI: 10.1001/Archpsyc.60.6.565 |
0.332 |
|
2003 |
Posthuma D, Baaré WF, Hulshoff Pol HE, Kahn RS, Boomsma DI, De Geus EJ. Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Research : the Official Journal of the International Society For Twin Studies. 6: 131-9. PMID 12723999 DOI: 10.1375/136905203321536254 |
0.304 |
|
2003 |
Sommer IE, Ramsey NF, Mandl RC, Kahn RS. Language lateralization in female patients with schizophrenia: an fMRI study. Schizophrenia Research. 60: 183-90. PMID 12591582 DOI: 10.1016/S0920-9964(02)00300-6 |
0.552 |
|
2003 |
Kahn R, Lieberman J, Charles C, Sharma T, Zipursky R, Gur R, Tohen M, Green A, McEvoy J, Perkins D, Hamer R, Nemeroff C, Rothschild A, Kuldau J, Strakowski S, et al. P.2.131 Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia European Neuropsychopharmacology. 13: S337. DOI: 10.1016/S0924-977X(03)92084-0 |
0.386 |
|
2003 |
Tuinier S, Fekkes D, Sijben A, Kahn R, Verhoeven W. Atypical antipsychotics : Glutamate, amino acids and monoaminergic parameters European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91969-9 |
0.526 |
|
2003 |
Sharma T, Lieberman J, McEvoy J, Perkins D, Hamer R, Zipursky R, Kahn R, Gur R, Centorrino F, Glick I, Green A, Nemeroff C, Rothschild A, Strakowski S, Tohen M, et al. S.14.05 Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia European Neuropsychopharmacology. 13: S134-S135. DOI: 10.1016/S0924-977X(03)91655-5 |
0.32 |
|
2003 |
van Raalten T, Ramsey N, Jansma J, Jager G, Kahn R. Automatization and information processing capacity in schizophrenia Schizophrenia Research. 60: 236. DOI: 10.1016/S0920-9964(03)81232-X |
0.551 |
|
2003 |
Cahn W, Pol HH, Schnack H, Mandl R, Collins D, Evans A, Kahn R. Progressive focal gray matter density changes in speech related areas in schizophrenia Schizophrenia Research. 60: 191. DOI: 10.1016/S0920-9964(03)81101-5 |
0.356 |
|
2003 |
Aleman A, Bocker K, Hijman R, De Haan E, Kahn R. Cognitive basis of hallucinations in schizophrenia: Role of top-down processing Schizophrenia Research. 60: 163. DOI: 10.1016/S0920-9964(03)81016-2 |
0.352 |
|
2003 |
Sitskoorn M, Aleman A, Ebisch S, Appels M, Kahn R. Meta-analysis of neurocognitive deficits in relatives of patients with schizophrenia: Evidence for a strong cognitive endophenotypic marker Schizophrenia Research. 60: 90. DOI: 10.1016/S0920-9964(03)80655-2 |
0.372 |
|
2003 |
Lieberman J, Charles HC, Sharma T, Zipursky R, Kahn R, Gur R, Tohen M, Green AI, McEvoy J, Perkins D, Hamer RM, Nemeroff C, Rothschild A, Kuldau J, Strakowski S, et al. Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia Schizophrenia Research. 60: 293. DOI: 10.1016/S0920-9964(03)80491-7 |
0.39 |
|
2003 |
McEvoy J, Lieberman J, Perkins D, Hamer R, Sharma T, Zipursky R, Kahn R, Gur R, Centorrino F, Glick I, Green A, Nemeroff C, Rothschild A, Strakowski S, Tohen M, et al. Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia Schizophrenia Research. 60: 313. DOI: 10.1016/S0920-9964(03)80257-8 |
0.321 |
|
2003 |
Ramsey N, Jansma M, Kahn R. Functionele mri en informatieverwerkingsstoornissen bij schizofrenie Neuropraxis. 7: 172-178. DOI: 10.1007/Bf03071069 |
0.475 |
|
2002 |
Sommer IE, Ramsey NF, Mandl RC, Kahn RS. Language lateralization in monozygotic twin pairs concordant and discordant for handedness. Brain : a Journal of Neurology. 125: 2710-8. PMID 12429598 DOI: 10.1093/Brain/Awf284 |
0.469 |
|
2002 |
Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, Schothorst PF, van Engeland H, Kahn RS. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Archives of General Psychiatry. 59: 1002-10. PMID 12418933 DOI: 10.1001/Archpsyc.59.11.1002 |
0.403 |
|
2002 |
Cahn W, Hulshoff Pol HE, Bongers M, Schnack HG, Mandl RC, Van Haren NE, Durston S, Koning H, Van Der Linden JA, Kahn RS. Brain morphology in antipsychotic-naïve schizophrenia: a study of multiple brain structures. The British Journal of Psychiatry. Supplement. 43: s66-72. PMID 12271803 DOI: 10.1192/Bjp.181.43.S66 |
0.393 |
|
2002 |
Aleman A, de Haan EH, Böcker KB, Hijman R, Kahn RS. Hallucinations in schizophrenia: imbalance between imagery and perception? Schizophrenia Research. 57: 315-6. PMID 12223265 DOI: 10.1016/S0920-9964(01)00291-2 |
0.377 |
|
2002 |
Ramsey NF, Koning HA, Welles P, Cahn W, van der Linden JA, Kahn RS. Excessive recruitment of neural systems subserving logical reasoning in schizophrenia. Brain : a Journal of Neurology. 125: 1793-807. PMID 12135970 DOI: 10.1093/Brain/Awf188 |
0.569 |
|
2002 |
Aleman A, Schutter DJ, Ramsey NF, van Honk J, Kessels RP, Hoogduin JM, Postma A, Kahn RS, de Haan EH. Functional anatomy of top-down visuospatial processing in the human brain: evidence from rTMS. Brain Research. Cognitive Brain Research. 14: 300-2. PMID 12067703 DOI: 10.1016/S0926-6410(02)00109-X |
0.517 |
|
2002 |
Scheepers FE, Gispen-De Wied CC, Westenberg HG, Kahn RS. Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia. Journal of Clinical Psychopharmacology. 22: 333-4. PMID 12006906 DOI: 10.1097/00004714-200206000-00016 |
0.609 |
|
2002 |
Aleman A, de Haan EH, Kahn RS. Insight and neurocognitive function in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 241-2. PMID 11983805 DOI: 10.1176/Jnp.14.2.241 |
0.384 |
|
2002 |
Sitskoorn MM, Nuyen J, Appels MC, van der Wee NJ, Kahn RS. Release from proactive inhibition in schizophrenia and its potential as a genotypic marker. Journal of Clinical and Experimental Neuropsychology. 24: 67-81. PMID 11935425 DOI: 10.1076/Jcen.24.1.67.971 |
0.635 |
|
2002 |
Raemaekers M, Jansma JM, Cahn W, Van der Geest JN, van der Linden JA, Kahn RS, Ramsey NF. Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3-dimensional event-related functional magnetic resonance imaging. Archives of General Psychiatry. 59: 313-20. PMID 11926931 DOI: 10.1001/Archpsyc.59.4.313 |
0.585 |
|
2002 |
d'Alfonso AA, Aleman A, Kessels RP, Schouten EA, Postma A, van Der Linden JA, Cahn W, Greene Y, de Haan EH, Kahn RS. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 77-9. PMID 11884659 DOI: 10.1176/Jnp.14.1.77 |
0.322 |
|
2002 |
Hulshoff Pol HE, Posthuma D, Baaré WF, De Geus EJ, Schnack HG, van Haren NE, van Oel CJ, Kahn RS, Boomsma DI. Twin-singleton differences in brain structure using structural equation modelling. Brain : a Journal of Neurology. 125: 384-90. PMID 11844738 DOI: 10.1093/Brain/Awf035 |
0.3 |
|
2002 |
Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG, Baaré WF, Kahn RS. Volume changes in gray matter in patients with schizophrenia. The American Journal of Psychiatry. 159: 244-50. PMID 11823266 DOI: 10.1176/Appi.Ajp.159.2.244 |
0.695 |
|
2002 |
Aleman A, Kahn RS. Top-down modulation, emotion, and hallucination Behavioral and Brain Sciences. 25: 578-578. DOI: 10.1017/S0140525X02220105 |
0.317 |
|
2002 |
Sommer I, Ramsey N, Graafmans D, Mandl R, Kahn R. How identical are monozygotic twins? An fMRI study on language lateralization European Psychiatry. 17: 11. DOI: 10.1016/S0924-9338(02)80047-5 |
0.466 |
|
2001 |
Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL, Evans AC, Kahn RS. Focal gray matter density changes in schizophrenia. Archives of General Psychiatry. 58: 1118-25. PMID 11735840 DOI: 10.1001/Archpsyc.58.12.1118 |
0.376 |
|
2001 |
van Oel CJ, Baaré WF, Hulshoff Pol HE, Haag J, Balazs J, Dingemans A, Kahn RS, Sitskoorn MM. Differentiating between low and high susceptibility to schizophrenia in twins: the significance of dermatoglyphic indices in relation to other determinants of brain development. Schizophrenia Research. 52: 181-93. PMID 11705712 DOI: 10.1016/S0920-9964(01)00153-0 |
0.421 |
|
2001 |
Sommer IE, Ramsey NF, Kahn RS. Language lateralization in schizophrenia, an fMRI study. Schizophrenia Research. 52: 57-67. PMID 11595392 DOI: 10.1016/S0920-9964(00)00180-8 |
0.539 |
|
2001 |
Jansma JM, Ramsey NF, Slagter HA, Kahn RS. Functional anatomical correlates of controlled and automatic processing. Journal of Cognitive Neuroscience. 13: 730-43. PMID 11564318 DOI: 10.1162/08989290152541403 |
0.529 |
|
2001 |
Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 468-75. PMID 11557160 DOI: 10.1016/S0893-133X(01)00250-0 |
0.585 |
|
2001 |
Baaré WF, Hulshoff Pol HE, Boomsma DI, Posthuma D, de Geus EJ, Schnack HG, van Haren NE, van Oel CJ, Kahn RS. Quantitative genetic modeling of variation in human brain morphology. Cerebral Cortex (New York, N.Y. : 1991). 11: 816-24. PMID 11532887 DOI: 10.1093/Cercor/11.9.816 |
0.306 |
|
2001 |
Aleman A, Kahn RS. Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 11: 289-93. PMID 11532383 DOI: 10.1016/S0924-977X(01)00097-9 |
0.366 |
|
2001 |
Staal WG, Hulshoff Pol HE, Schnack HG, van Haren NE, Seifert N, Kahn RS. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. The American Journal of Psychiatry. 158: 1140-2. PMID 11431237 DOI: 10.1176/Appi.Ajp.158.7.1140 |
0.677 |
|
2001 |
Ramsey NF, Sommer IE, Rutten GJ, Kahn RS. Combined analysis of language tasks in fMRI improves assessment of hemispheric dominance for language functions in individual subjects. Neuroimage. 13: 719-33. PMID 11305899 DOI: 10.1006/Nimg.2000.0722 |
0.501 |
|
2001 |
Selten JP, Veen N, Feller W, Blom JD, Schols D, Camoenië W, Oolders J, van der Velden M, Hoek HW, Rivero VM, van der Graaf Y, Kahn R. Incidence of psychotic disorders in immigrant groups to The Netherlands. The British Journal of Psychiatry : the Journal of Mental Science. 178: 367-72. PMID 11282817 DOI: 10.1192/Bjp.178.4.367 |
0.321 |
|
2001 |
Sommer I, Ramsey N, Kahn R, Aleman A, Bouma A. Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. 178: 344-51. PMID 11282814 DOI: 10.1192/Bjp.178.4.344 |
0.57 |
|
2001 |
Schnack HG, Pol HEH, Baaré WFC, Staal WG, Viergever MA, Kahn RS. Automated separation of gray and white matter from MR images of the human brain. Neuroimage. 13: 230-237. PMID 11133325 DOI: 10.1006/Nimg.2000.0669 |
0.615 |
|
2001 |
Scheepers FE, de Wied CC, Hulshoff Pol HE, van de Flier W, van der Linden JA, Kahn RS. The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 47-54. PMID 11106875 DOI: 10.1016/S0893-133X(00)00172-X |
0.342 |
|
2001 |
Wee NVd, Jansma M, Megen Hv, Westenberg H, Kahn RS, Ramsey N. Reduced efficacy of the spatial working memory system in obsessive compulsive disorder Neuroimage. 13: 1109. DOI: 10.1016/S1053-8119(01)92436-X |
0.481 |
|
2001 |
Ramsey N, van Atteveldt N, Cahn W, Kahn R. Top-down attentional modulation of primary auditory cortex in schizophrenia Neuroimage. 13: 1092. DOI: 10.1016/S1053-8119(01)92420-6 |
0.544 |
|
2001 |
Raemaekers M, Jansma J, Cahn W, Van der Geest J, Van der Linden J, Kahn R, Ramsey N. Neuronal substrate of the saccadic inhibition deficit in schizophrenia investigated with 3D event related fMRI Neuroimage. 13: 1091. DOI: 10.1016/S1053-8119(01)92419-X |
0.547 |
|
2001 |
Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins L, Evans AC, Kahn RS. Focal brain abnormalities in schizophrenia detected by linear regression analysis of magnetic resonance gray matter density maps Neuroimage. 13: 1060. DOI: 10.1016/S1053-8119(01)92391-2 |
0.345 |
|
2001 |
Sommer I, Ramsey N, Graafmans D, Mandl R, Bouma A, Kahn R. Mirror-imaged language activation patterns in healthy monozygotic twins. Neuroimage. 13: 607. DOI: 10.1016/S1053-8119(01)91950-0 |
0.474 |
|
2000 |
Posthuma D, de Geus EJ, Neale MC, Hulshoff Pol HE, Baaré WEC, Kahn RS, Boomsma D. Multivariate genetic analysis of brain structure in an extended twin design. Behavior Genetics. 30: 311-9. PMID 11206086 DOI: 10.1023/A:1026501501434 |
0.303 |
|
2000 |
Jansma JM, Ramsey NF, Coppola R, Kahn RS. Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage. 12: 688-97. PMID 11112400 DOI: 10.1006/Nimg.2000.0645 |
0.518 |
|
2000 |
Pol HEH, Van Der Flier WM, Schnack HG, Tulleken CAF, Ramos LM, Van Ree JM, Kahn RS. Frontal lobe damage and thalamic volume changes Neuroreport. 11: 3039-3041. PMID 11006990 DOI: 10.1097/00001756-200009110-00042 |
0.54 |
|
2000 |
Staal WG, Hijman R, Hulshoff Pol HE, Kahn RS. Neuropsychological dysfunctions in siblings discordant for schizophrenia. Psychiatry Research. 95: 227-35. PMID 10974361 DOI: 10.1016/S0165-1781(00)00172-4 |
0.679 |
|
2000 |
Hulshoff Pol HE, Hoek HW, Susser E, Brown AS, Dingemans A, Schnack HG, van Haren NE, Pereira Ramos LM, Gispen-de Wied CC, Kahn RS. Prenatal exposure to famine and brain morphology in schizophrenia. The American Journal of Psychiatry. 157: 1170-2. PMID 10873931 DOI: 10.1016/S0920-9964(00)90321-9 |
0.381 |
|
2000 |
Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn ML, Jellema K, Kahn RS. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. The American Journal of Psychiatry. 157: 416-21. PMID 10698818 DOI: 10.1176/appi.ajp.157.3.416 |
0.665 |
|
2000 |
Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. The effects of a sub-anaesthetic dose of ketamine on human selective attention Neuropsychopharmacology. 22: 293-302. PMID 10693157 DOI: 10.1016/S0893-133X(99)00118-9 |
0.569 |
|
2000 |
Mandl R, Jansma J, Ramsey N, Collins D, Slagter H, Kahn R. On the validity of associating stereotactic coordinates with anatomical nomenclature Neuroimage. 11: S539. DOI: 10.1016/S1053-8119(00)91470-8 |
0.463 |
|
2000 |
Ramsey N, Sommer I, Kahn R. Combining language tasks in fMRI analysis improves reliability of the derived laterality index Neuroimage. 11: S318. DOI: 10.1016/S1053-8119(00)91250-3 |
0.472 |
|
2000 |
Jansma M, Ramsey N, Kahn R. Cognitive load and brain activity in patients with schizophrenia Neuroimage. 11: S88. DOI: 10.1016/S1053-8119(00)91021-8 |
0.565 |
|
2000 |
Sommer IE, Ramsey NF, Kahn RS. Positive symptoms in schizophrenia are associated with decreased lateralization on functional MRI Schizophrenia Research. 41: 159-160. DOI: 10.1016/S0920-9964(00)90686-8 |
0.559 |
|
2000 |
Jansma J, Ramsey N, Kahn R. Brain correlates of ineffective shifting between controlled and automatic processing in schizophrenia Schizophrenia Research. 41: 135. DOI: 10.1016/S0920-9964(00)90628-5 |
0.578 |
|
2000 |
Ramsey N, Welles P, Kahn R. Reduced efficiency of brain systems subserving deductive reasoning in medication-naive schizophrenic patients Schizophrenia Research. 41: 135. DOI: 10.1016/S0920-9964(00)90627-3 |
0.438 |
|
2000 |
Staal W, Hulshoff Pol H, Schnack H, Kahn R. Structural brain abnormalities in schizophrenia in relation to outcome Schizophrenia Research. 41: 122. DOI: 10.1016/S0920-9964(00)90596-6 |
0.677 |
|
1999 |
Sommer IE, Ramsey NF, Bouma A, Kahn RS. Cerebral mirror-imaging in a monozygotic twin. Lancet. 354: 1445-6. PMID 10543677 DOI: 10.1016/S0140-6736(99)04130-6 |
0.488 |
|
1999 |
Aleman A, Hijman R, de Haan EH, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. The American Journal of Psychiatry. 156: 1358-66. PMID 10484945 DOI: 10.1176/Ajp.156.9.1358 |
0.342 |
|
1999 |
Selten JP, Brown AS, Moons KG, Slaets JP, Susser ES, Kahn RS. Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands. Schizophrenia Research. 38: 85-91. PMID 10463456 DOI: 10.1016/S0920-9964(99)00005-5 |
0.335 |
|
1999 |
Van Berckel BNM, Evenblij CN, Van Loon BJAM, Maas MF, Van Der Geld MAM, Wynne HJ, Van Ree JM, Kahn RS. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: A double-blind, parallel, placebo-controlled study Neuropsychopharmacology. 21: 203-210. PMID 10432468 DOI: 10.1016/S0893-133X(99)00014-7 |
0.565 |
|
1999 |
Staal WG, Hulshoff Pol HE, Kahn RS. Outcome of schizophrenia in relation to brain abnormalities. Schizophrenia Bulletin. 25: 337-48. PMID 10416735 DOI: 10.1093/Oxfordjournals.Schbul.A033382 |
0.661 |
|
1999 |
Baaré WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS. Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biological Psychiatry. 45: 1597-605. PMID 10376121 DOI: 10.1016/S0006-3223(98)00266-2 |
0.375 |
|
1999 |
Oranje B, Van Berckel BNM, Kemner C, Van Ree JM, Kahn RS, Verbaten MN. P50 suppression and prepulse inhibition of the startle reflex in humans: A correlational study Biological Psychiatry. 45: 883-890. PMID 10202576 DOI: 10.1016/S0006-3223(98)00128-0 |
0.542 |
|
1999 |
van der Wee N, Ramsey N, Jansma J, van Megen H, Westenberg H, Kahn R. Spatial working memory in obsessive compulsive disorder: A three-dimensional functional magnetic resonance imaging study European Neuropsychopharmacology. 9: 309. DOI: 10.1016/S0924-977X(99)80404-0 |
0.492 |
|
1998 |
Staal WG, Hulshoff Pol HE, Schnack H, van der Schot AC, Kahn RS. Partial volume decrease of the thalamus in relatives of patients with schizophrenia. The American Journal of Psychiatry. 155: 1784-6. PMID 9842796 DOI: 10.1176/Ajp.155.12.1784 |
0.701 |
|
1998 |
Jansen LM, Gispen-de Wied CC, Gademan PJ, De Jonge RC, van der Linden JA, Kahn RS. Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophrenia Research. 33: 87-94. PMID 9783348 DOI: 10.1016/S0920-9964(98)00066-8 |
0.347 |
|
1998 |
Ramsey NF, van den Brink JS, van Muiswinkel AM, Folkers PJ, Moonen CT, Jansma JM, Kahn RS. Phase navigator correction in 3D fMRI improves detection of brain activation: quantitative assessment with a graded motor activation procedure. Neuroimage. 8: 240-8. PMID 9758738 DOI: 10.1006/Nimg.1998.0358 |
0.517 |
|
1998 |
Van Berckel BNM, Lipsch C, Gispen-de Wied C, Wynne HJ, Blankenstein MA, Van Ree JM, Kahn RS. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers Psychopharmacology. 138: 190-197. PMID 9718289 DOI: 10.1007/S002130050662 |
0.513 |
|
1998 |
Van Berckel BNM, Oranje B, Van Ree JM, Verbaten MN, Kahn RS. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects Psychopharmacology. 137: 271-281. PMID 9683005 DOI: 10.1007/S002130050620 |
0.536 |
|
1998 |
Ramsey N, Koning H, Kahn R. 3D fMRI of functions involved in setshifting Neuroimage. 7: S889. DOI: 10.1016/S1053-8119(18)31722-1 |
0.476 |
|
1998 |
Jansma J, Ramsey N, Kahn R. Experimental design for separation of two simultaneously administered stimulation protocols Neuroimage. 7: S561. DOI: 10.1016/S1053-8119(18)31394-6 |
0.444 |
|
1998 |
Staal W, Pol H, Schnack H, van der Schot A, Kahn R. Thalamic and ventricular volumes in siblings discordant for schizophrenia and normal controls European Neuropsychopharmacology. 8: S217-S218. DOI: 10.1016/S0924-977X(98)80353-2 |
0.682 |
|
1998 |
Hulshoff Pol H, Staal W, Baaré W, Schnack H, Kahn R. Genetic risk to develop schizophrenia and volume decrease of the thalamus European Neuropsychopharmacology. 8: S94-S95. DOI: 10.1016/S0924-977X(98)80067-9 |
0.669 |
|
1998 |
Staal W, HulshoffPol H, Schnack H, van der Schot A, Gispen- de Wied C, Hijman R, Kahn R. Thalamic volumes in patients with schizophrenia, healthy siblings and normal controls Schizophrenia Research. 29: 139-140. DOI: 10.1016/S0920-9964(97)88655-0 |
0.693 |
|
1998 |
Jansma J, Ramsey N, van der Linden J, Kahn R. Schizophrenic patients exhibit increased sensorimotor cortex activation with equal performance level Schizophrenia Research. 29: 114. DOI: 10.1016/S0920-9964(97)88588-X |
0.516 |
|
1998 |
Ramsey N, Jansma J, Cahn W, Mali W, Kahn R. Motion-corrected 3D fmri assessment of visual cortex: Schizophrenic patients show the same regional response to photic stimulation as controls Schizophrenia Research. 29: 112. DOI: 10.1016/S0920-9964(97)88584-2 |
0.501 |
|
1997 |
Van Berckel BNM, Lipsch C, Timp S, Wied CGd, Wynne H, Van Ree JM, Kahn RS. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects Neuropsychopharmacology. 16: 317-324. PMID 9109102 DOI: 10.1016/S0893-133X(96)00196-0 |
0.449 |
|
1997 |
Schnack HG, Hulshoff Pol HE, Staal W, Vincke K, Niessen WM, Viergeve MA, Kahn RS. Application of a nearly automatic image scale space linking scheme to segment gray and white matter and intracranial volumes on MR images Schizophrenia Research. 24: 155. DOI: 10.1016/S0920-9964(97)82445-0 |
0.595 |
|
1996 |
van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients. Biological Psychiatry. 40: 1298-300. PMID 8959296 DOI: 10.1016/S0006-3223(96)00311-3 |
0.651 |
|
1996 |
Megen HJGMv, Westenberg HGM, Boer JAD, Kahn R. The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder. European Neuropsychopharmacology. 6: 187-194. PMID 8880078 DOI: 10.1016/0924-977X(96)00018-1 |
0.3 |
|
1996 |
Kalkman J, Hoek H, Susser E, Kahn R. Case-control and neuro-imaging study in persons with schizophrenia after prenatal exposure to the Dutch Famine in 1945 European Neuropsychopharmacology. 6: S4-102. DOI: 10.1016/0924-977X(96)83045-8 |
0.344 |
|
1996 |
Jansma J, Ramsey N, Meinders L, Mali W, Kahn R. Comparison of brain activity patterns during finger opposition with and without tactile stimulation using a BOLD-fMRI method European Neuropsychopharmacology. 6: S4-167. DOI: 10.1016/0924-977X(96)82980-4 |
0.5 |
|
1993 |
Davidson M, Kahn R, Stern RG, Hirschowitz J, Apter S, Knott P, Davis KL. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia Psychiatry Research-Neuroimaging. 46: 151-163. PMID 8483974 DOI: 10.1016/0165-1781(93)90017-B |
0.318 |
|
1993 |
Harvey P, Kahn R, Davidson M. Neuropsychological correlates of central monoamine function in chronic schizophrenia European Neuropsychopharmacology. 3: 401-402. DOI: 10.1016/0924-977X(93)90195-R |
0.37 |
|
1993 |
Harvey P, Kahn R, Davidson M, Davis KL. Neuropsychological correlates of central monoamine function in schizophrenia Schizophrenia Research. 9: 177. DOI: 10.1016/0920-9964(93)90348-M |
0.382 |
|
1992 |
Kahn RS, van Praag HM. Panic disorder: a biological perspective. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 2: 1-20. PMID 1638169 DOI: 10.1016/0924-977X(92)90031-3 |
0.423 |
|
1992 |
Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM. A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects. Psychopharmacology. 106: 388-90. PMID 1533289 DOI: 10.1007/BF02245423 |
0.434 |
|
1992 |
Asnis GM, Wetzler S, Sanderson WC, Kahn RS, van Praag HM. Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Research. 43: 65-76. PMID 1438618 DOI: 10.1016/0165-1781(92)90142-P |
0.457 |
|
1992 |
Kahn R, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M. Serotonin function in schizophrenia: Effects of meta- chlorophenylpiperazine in schizophrenia patients and healthy subjects Psychiatry Research-Neuroimaging. 43: 1-12. PMID 1332094 DOI: 10.1016/0165-1781(92)90136-Q |
0.357 |
|
1992 |
Kahn RS, Siever L, Knott P, Amin F, Dumont K, Moore C, Davidson M. SEROTONIN DYSFUNCTION IN TREATMENT-REFRACTORY SCHIZOPHRENIA Clinical Neuropharmacology. 15: 168B. DOI: 10.1097/00002826-199202001-00323 |
0.368 |
|
1992 |
Kahn RS, Davidson M, Knott P, Stern RG, Webster L, Davis KL. EFFECT OF NEUROLEPTIC TREATMENT ON CSF MONOAMINE METABOLITES: RELEVANCE OF 5HT-DA INTERACTIONS IN SCHIZOPHRENIA. Clinical Neuropharmacology. 15: 119B. DOI: 10.1097/00002826-199202001-00230 |
0.316 |
|
1992 |
Kahn R, Siever L, Knott P, Stern R, Amin F, Dumont K, Apter S, Davidson M. m-chlorophenylpiperazine as a probe of serotonin function in schizophrenia Schizophrenia Research. 6: 138. DOI: 10.1016/0920-9964(92)90199-F |
0.354 |
|
1992 |
Kahn R, Davidson M, Knott P, Stern R, Amin F, Webster L, Apter S, Davis K. Effect of haloperidol on CSF monoamine metabolites in schizophrenia. Symptomatic improvement is related to altered dopamine-serotonin interaction Schizophrenia Research. 6: 118. DOI: 10.1016/0920-9964(92)90155-X |
0.35 |
|
1992 |
Stern R, Kahn R, Davidson M, Harvey P, Amin F, Apter S, DuMont K, Hirschowitz J, Davis K. Significant decrease in psychopathology within three days of haloperidol treatment in chronic schizophrenia Schizophrenia Research. 6: 109-110. DOI: 10.1016/0920-9964(92)90134-Q |
0.348 |
|
1991 |
Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Archives of General Psychiatry. 48: 910-3. PMID 1929760 DOI: 10.1001/Archpsyc.1991.01810340042005 |
0.305 |
|
1991 |
Wetzler S, Kahn RS, Asnis GM, Korn M, van Praag HM. Serotonin receptor sensitivity and aggression. Psychiatry Research. 37: 271-9. PMID 1891509 DOI: 10.1016/0165-1781(91)90063-U |
0.443 |
|
1991 |
Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biological Psychiatry. 30: 770-8. PMID 1751620 DOI: 10.1016/0006-3223(91)90233-C |
0.52 |
|
1991 |
Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. The American Journal of Psychiatry. 148: 1474-86. PMID 1681750 DOI: 10.1176/Ajp.148.11.1474 |
0.374 |
|
1991 |
Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research. 37: 25-34. PMID 1650487 DOI: 10.1016/0165-1781(91)90103-V |
0.447 |
|
1991 |
Stern R, Kahn R, Harvey P, Cooper M, Kerman B, Apter S, Davidson M. Evidence for an early antipsychotic effect of neuroleptics in patients with chronic schizophrenia Schizophrenia Research. 4: 294-295. DOI: 10.1016/0920-9964(91)90174-P |
0.38 |
|
1990 |
Kahn RS, van Praag HM. Panic disorder: a presynaptic serotonin defect? Psychiatry Research. 31: 209-10. PMID 2326399 DOI: 10.1016/0165-1781(90)90123-M |
0.483 |
|
1990 |
Wetzler S, Kahn RS, Cahn W, van Praag HM, Asnis GM. Psychological test characteristics of depressed and panic patients. Psychiatry Research. 31: 179-92. PMID 2326397 DOI: 10.1016/0165-1781(90)90120-T |
0.512 |
|
1990 |
Kalus O, Kahn RS, Wetzler S, Asnis GM, van Praag HM. Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks. Biological Psychiatry. 28: 1053-7. PMID 2288999 DOI: 10.1016/0006-3223(90)90606-3 |
0.422 |
|
1990 |
Van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology. Annals of the New York Academy of Sciences. 600: 501-10. PMID 2252329 |
0.458 |
|
1990 |
Kahn RS, Kalus O, Wetzler S, Cahn W, Asnis GM, van Praag HM. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Psychiatry Research. 33: 189-98. PMID 2243896 DOI: 10.1016/0165-1781(90)90073-E |
0.423 |
|
1990 |
Kahn RS, Wetzler S, Asnis GM, Papolos D, van Praag HM. Serotonin receptor sensitivity in major depression. Biological Psychiatry. 28: 358-62. PMID 2204434 DOI: 10.1016/0006-3223(90)90663-M |
0.394 |
|
1990 |
Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology. 100: 339-44. PMID 2156278 DOI: 10.1007/BF02244603 |
0.426 |
|
1990 |
van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S. Monoamines and abnormal behaviour. A multi-aminergic perspective. The British Journal of Psychiatry : the Journal of Mental Science. 157: 723-34. PMID 1980627 |
0.456 |
|
1989 |
Kahn RS, Cahn W, van Praag HM. [Pathogenesis of panic disorders]. Nederlands Tijdschrift Voor Geneeskunde. 133: 498-501. PMID 2651934 |
0.42 |
|
1988 |
Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G. Serotonin and anxiety revisited. Biological Psychiatry. 23: 189-208. PMID 3275471 DOI: 10.1016/0006-3223(88)90091-1 |
0.424 |
|
1988 |
Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T. Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Research. 25: 101-4. PMID 3217461 DOI: 10.1016/0165-1781(88)90163-1 |
0.451 |
|
1988 |
van Praag HM, Kahn RS. L-5-hydroxytryptophan in depression and anxiety. Schweizerische Rundschau Fã¼R Medizin Praxis = Revue Suisse De Mã©Decine Praxis. 77: 40-6. PMID 3055148 |
0.38 |
|
1988 |
Kahn RS, Asnis GM, Wetzler S, van Praag HM. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology. 96: 360-4. PMID 2906153 DOI: 10.1007/BF00216062 |
0.434 |
|
1987 |
Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. International Clinical Psychopharmacology. 2: 33-45. PMID 3312397 DOI: 10.1097/00004850-198701000-00003 |
0.656 |
|
1987 |
den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology. 2: 21-32. PMID 3117876 DOI: 10.1097/00004850-198701000-00002 |
0.65 |
|
1987 |
van Praag HM, Kahn RS, Asnis GM, Wetzler S, Brown SL, Bleich A, Korn ML. Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. Journal of Affective Disorders. 13: 1-8. PMID 2959695 DOI: 10.1016/0165-0327(87)90067-X |
0.435 |
|
1985 |
Kahn RS, Westenberg HG. L-5-hydroxytryptophan in the treatment of anxiety disorders. Journal of Affective Disorders. 8: 197-200. PMID 3157732 DOI: 10.1016/0165-0327(85)90046-1 |
0.525 |
|
1984 |
Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11: 329-46. PMID 6204351 DOI: 10.1016/0165-1781(84)90006-4 |
0.757 |
|
1982 |
Van Ree JM, Innemee H, Louwerens JW, Kahn RS, De Wied D. Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine. Neuropharmacology. 21: 1095-101. PMID 6184639 DOI: 10.1016/0028-3908(82)90166-6 |
0.463 |
|
Show low-probability matches. |